"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","58/91","481/2914",7.42566995587374e-25,4.12124682550992e-22,2.54817726906825e-22,"CCND1/CDK4/CTNNB1/FOXO1/MAPK1/MAPK3/MYC/NR4A1/RB1/RBL1/SMAD3/SMAD7/AKT2/AKT3/CREB1/CREBBP/NOTCH1/PPARGC1A/PRKAA1/SMAD2/SMAD4/CASP1/CASP6/HDAC2/STAT1/CDK1/CSNK2A1/E2F1/JUN/PIN1/TP53/CDKN1A/EP300/GSK3B/PRKAA2/PTEN/STK11/AXIN1/HES1/NR3C1/SNW1/FOXO3/FOXO4/TCF7L2/AR/SP1/NR2F1/TAF1/MYBL2/VDR/ESRRA/NR2C2/MEF2C/SMAD1/ATF2/JUNB/SREBF1/SOX2",58
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","58/91","499/2914",5.6215024637392e-24,1.55996693368763e-21,9.64531475357357e-22,"CCND1/CDK4/CTNNB1/FOXO1/MAPK1/MAPK3/MYC/NR4A1/RB1/RBL1/SMAD3/SMAD7/AKT2/AKT3/CREB1/CREBBP/NOTCH1/PPARGC1A/PRKAA1/SMAD2/SMAD4/CASP1/CASP6/HDAC2/STAT1/CDK1/CSNK2A1/E2F1/JUN/PIN1/TP53/CDKN1A/EP300/GSK3B/PRKAA2/PTEN/STK11/AXIN1/HES1/NR3C1/SNW1/FOXO3/FOXO4/TCF7L2/AR/SP1/NR2F1/TAF1/MYBL2/VDR/ESRRA/NR2C2/MEF2C/SMAD1/ATF2/JUNB/SREBF1/SOX2",58
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","34/91","268/2914",7.9537173717187e-14,1.22296853938455e-11,7.56164521269535e-12,"CTNNB1/FOXO1/MAPK1/MAPK3/MYC/NR4A1/SMAD3/AKT2/AKT3/CREB1/CREBBP/CSK/NOTCH1/SMAD2/SMAD4/STAT3/TGFBR1/TGFBR2/GSK3A/HDAC2/STAT1/RAF1/CDKN1A/EP300/GSK3B/PTEN/AXIN1/HES1/LRP5/LRP6/SNW1/FOXO3/FOXO4/TCF7L2",34
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","18/91","62/2914",8.81418767123997e-14,1.22296853938455e-11,7.56164521269535e-12,"CCND1/CDK4/MAPK1/MAPK3/RB1/AKT2/AKT3/PPARGC1A/SMAD4/STAT1/CDK1/CDKN1A/GSK3B/HES1/NR3C1/AR/ESRRA/SMAD1",18
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","16/91","49/2914",3.1080224820292e-13,3.44990495505241e-11,2.13308490345583e-11,"FOXO1/SMAD3/AKT2/AKT3/CREBBP/PPARGC1A/SMAD2/SMAD4/HDAC2/CDKN1A/EP300/STK11/NR3C1/FOXO3/FOXO4/SREBF1",16
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","10/91","19/2914",3.93299249691357e-11,3.63801805964505e-09,2.24939570876109e-09,"FOXO1/SMAD3/PPARGC1A/SMAD2/SMAD4/HDAC2/NR3C1/FOXO3/FOXO4/SREBF1",10
"R-HSA-1643685","R-HSA-1643685","Disease","39/91","443/2914",1.05608454223363e-10,8.37324172770953e-09,5.17719640252879e-09,"CDK4/CTNNB1/FOXO1/MAPK1/MAPK3/MYC/NR4A1/SMAD3/AKT2/AKT3/CREB1/CREBBP/CSK/NOTCH1/SMAD2/SMAD4/STAT3/TGFBR1/TGFBR2/CDC25A/CDH1/GSK3A/HDAC2/STAT1/JUN/RAF1/CDKN1A/EP300/GSK3B/PTEN/AXIN1/HES1/LRP5/LRP6/SNW1/FOXO3/FOXO4/TCF7L2/TAF1",39
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","14/91","53/2914",2.71654616744344e-10,1.88460390366389e-08,1.16525532971916e-08,"CCND1/CTNNB1/MYC/SMAD3/CREBBP/NOTCH1/SMAD4/TP53/CDKN1A/EP300/HES1/SNW1/FOXO3/TCF7L2",14
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","10/91","24/2914",7.34275596596703e-10,4.52803284567967e-08,2.79969408760848e-08,"FOXO1/NR4A1/AKT2/AKT3/CREB1/GSK3A/CDKN1A/GSK3B/FOXO3/FOXO4",10
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","35/91","397/2914",1.55933624751665e-09,8.65431617371739e-08,5.3509854388466e-08,"CDK4/CTNNB1/FOXO1/MAPK1/MAPK3/MYC/SMAD3/TCF4/AKT2/AKT3/CREB1/CREBBP/NOTCH1/PPARGC1A/RHOA/ROCK2/SMAD2/SMAD4/STAT3/CSNK2A1/E2F1/JUN/RPS6KA5/CDKN1A/EP300/GSK3B/PAK1/HES1/SNW1/WNT1/FOXO3/SREBF2/MEF2C/SREBF1/SOX2",35
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","19/91","124/2914",3.14324600045497e-09,1.58591048204773e-07,9.80572436505569e-08,"MYC/SMAD3/SMAD7/MAP3K7/RHOA/SMAD2/SMAD4/TGFBR1/TGFBR2/CDC25A/CDK1/TP53/EP300/PTEN/AXIN1/FOXO4/AR/HIF1A/SMAD1",19
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","15/91","80/2914",1.04305723785882e-08,4.82413972509705e-07,2.98277771528049e-07,"MYC/SMAD3/SMAD7/MAP3K7/SMAD2/SMAD4/TGFBR1/CDC25A/TP53/PTEN/AXIN1/FOXO4/AR/HIF1A/SMAD1",15
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","9/91","24/2914",1.68916900313795e-08,7.21145228262741e-07,4.45885906901192e-07,"MYC/RBL1/SMAD3/SMAD7/SMAD2/SMAD4/SNW1/SP1/JUNB",9
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","7/91","14/2914",6.6072280939303e-08,2.61929399437951e-06,1.61951605911374e-06,"FOXO1/SMAD3/SMAD2/SMAD4/CDKN1A/FOXO3/FOXO4",7
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","8/91","23/2914",2.21876718944949e-07,8.2094386009631e-06,5.07591651761777e-06,"CCND1/CREBBP/NOTCH1/E2F1/JUN/TP53/EP300/SNW1",8
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","21/91","194/2914",2.39246803097513e-07,8.29887348244499e-06,5.1312143295914e-06,"RBL1/AKT2/AKT3/CREBBP/PRKAA1/CASP1/CASP6/HDAC2/CDK1/CSNK2A1/E2F1/JUN/PIN1/TP53/CDKN1A/EP300/PRKAA2/PTEN/STK11/TAF1/ATF2",21
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","12/91","63/2914",2.98989673750347e-07,9.76113346655546e-06,6.03533335248379e-06,"MYC/RBL1/SMAD3/SMAD7/RHOA/SMAD2/SMAD4/TGFBR1/TGFBR2/SNW1/SP1/JUNB",12
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","8/91","24/2914",3.24369233401734e-07,1.00013846965535e-05,6.18388129175236e-06,"FOXO1/AKT2/AKT3/CREBBP/NOTCH1/EP300/HES1/SNW1",8
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","15/91","104/2914",4.0862938863725e-07,1.19362795101933e-05,7.38023161749271e-06,"CCND1/MYC/SMAD3/CREB1/CREBBP/NOTCH1/HDAC2/STAT1/E2F1/JUN/TP53/EP300/HES1/SNW1/HIF1A",15
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","15/91","108/2914",6.77654446234971e-07,1.88049108830204e-05,1.16271236564527e-05,"CCND1/MAPK1/MAPK3/MYC/AKT2/AKT3/CREB1/CREBBP/JUN/EP300/AXIN1/FOXO3/SP1/FOXA1/ATF2",15
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","9/91","36/2914",8.92922268981901e-07,2.35986599659502e-05,1.45911107613083e-05,"MYC/RBL1/SMAD3/SMAD7/SMAD2/SMAD4/SNW1/SP1/JUNB",9
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","6/91","13/2914",1.13216978917866e-06,2.85615560451888e-05,1.76596818790546e-05,"FOXO1/CREBBP/EP300/STK11/FOXO3/FOXO4",6
"R-HSA-69206","R-HSA-69206","G1/S Transition","11/91","60/2914",1.45838535023789e-06,3.51914725818273e-05,2.17589759348994e-05,"CCND1/CDK4/MYC/RB1/RBL1/AKT2/AKT3/CDC25A/CDK1/E2F1/CDKN1A",11
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","13/91","86/2914",1.52456357624735e-06,3.52555327007199e-05,2.17985844673963e-05,"MYC/RBL1/SMAD3/SMAD7/RHOA/SMAD2/SMAD4/TGFBR1/TGFBR2/SNW1/SP1/SMAD1/JUNB",13
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","8/91","29/2914",1.66471398873802e-06,3.6956650549984e-05,2.28503899085724e-05,"CCND1/CREBBP/NOTCH1/E2F1/JUN/TP53/EP300/SNW1",8
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","9/91","39/2914",1.86050346377246e-06,3.97080489184734e-05,2.45515864341817e-05,"CCND1/CDK4/MYC/RB1/AKT2/AKT3/CDC25A/E2F1/CDKN1A",9
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","6/91","14/2914",1.93174292035816e-06,3.97080489184734e-05,2.45515864341817e-05,"AKT2/AKT3/HDAC2/PIN1/TP53/EP300",6
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","8/91","30/2914",2.21247387191779e-06,4.38543928183705e-05,2.71152812874135e-05,"MAPK1/MAPK3/CREB1/JUN/RPS6KA5/MEF2C/ATF1/ATF2",8
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","9/91","40/2914",2.33960909099663e-06,4.47752774311425e-05,2.76846665577097e-05,"CCND1/CDK4/MYC/RB1/AKT2/AKT3/CDC25A/E2F1/CDKN1A",9
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","16/91","136/2914",2.73433467169821e-06,5.05851914264169e-05,3.12769509815304e-05,"CCND1/MAPK1/MAPK3/MYC/AKT2/AKT3/CREB1/CREBBP/JUN/EP300/AXIN1/FOXO3/SP1/FOXA1/ATF2/SREBF1",16
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","12/91","77/2914",2.87461520556974e-06,5.14648851319745e-05,3.18208678103815e-05,"CCND1/CDK4/MYC/RB1/RBL1/AKT2/AKT3/CDC25A/CDK1/E2F1/CDKN1A/MYBL2",12
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","18/91","172/2914",3.36797226313105e-06,5.84132689386792e-05,3.6117070979629e-05,"FOXO1/MAPK1/MAPK3/NR4A1/AKT2/AKT3/CREB1/GSK3A/HDAC2/CSNK2A1/JUN/TP53/CDKN1A/GSK3B/PTEN/FOXO3/FOXO4/ATF2",18
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","19/91","191/2914",3.71383265481911e-06,6.12022564935914e-05,3.78415089936667e-05,"CCND1/CDK4/MAPK1/MAPK3/MYC/RB1/RBL1/AKT2/AKT3/CDC25A/CDK1/CSNK2A1/E2F1/TP53/CDKN1A/EP300/GSK3B/FOXM1/MYBL2",19
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","7/91","23/2914",3.74932742483263e-06,6.12022564935914e-05,3.78415089936667e-05,"CDK4/MAPK1/MAPK3/RB1/E2F1/TP53/SP1",7
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","7/91","24/2914",5.15960432718652e-06,7.95439000441256e-05,4.91821932942341e-05,"MAPK1/MAPK3/RB1/SMAD4/HES1/AR/SMAD1",7
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","7/91","24/2914",5.15960432718652e-06,7.95439000441256e-05,4.91821932942341e-05,"CCND1/MAPK1/MAPK3/AKT2/AKT3/CREB1/FOXO3",7
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","5/91","10/2914",5.92925964843023e-06,8.89388947264535e-05,5.49911421163089e-05,"FOXO1/CREBBP/EP300/FOXO3/FOXO4",5
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","6/91","17/2914",7.3788880827564e-06,0.000107770602261311,6.66348342099331e-05,"SMAD3/CREBBP/NOTCH1/EP300/HES1/SNW1",6
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","10/91","59/2914",9.55184198037827e-06,0.000135930058951537,8.4045897047323e-05,"MAPK1/MAPK3/AKT2/AKT3/HDAC2/CSNK2A1/JUN/TP53/PTEN/ATF2",10
"R-HSA-9614399","R-HSA-9614399","Regulation of localization of FOXO transcription factors","5/91","11/2914",1.06030923569965e-05,0.00014608404973714,9.03241350674396e-05,"FOXO1/AKT2/AKT3/FOXO3/FOXO4",5
"R-HSA-9013508","R-HSA-9013508","NOTCH3 Intracellular Domain Regulates Transcription","6/91","18/2914",1.07917946652662e-05,0.00014608404973714,9.03241350674396e-05,"CREBBP/NOTCH1/STAT1/EP300/HES1/SNW1",6
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","7/91","27/2914",1.22616674189008e-05,0.000162029176606903,0.000100183047081746,"CDK4/MYC/CREB1/STAT3/E2F1/CDKN1A/EP300",7
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","9/91","49/2914",1.3941491087368e-05,0.000179942501243936,0.000111258900721713,"CCND1/MYC/CREBBP/JUN/EP300/AXIN1/SP1/FOXA1/ATF2",9
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","6/91","19/2914",1.53786584365642e-05,0.000193980805279389,0.000119938819385644,"MYC/RBL1/CDC25A/CDK1/E2F1/MYBL2",6
"R-HSA-210744","R-HSA-210744","Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells","5/91","12/2914",1.77301064872235e-05,0.000218671313342424,0.000135205022569237,"CREBBP/NOTCH1/EP300/HES1/SNW1",5
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","13/91","108/2914",2.05185662379013e-05,0.000247560962218157,0.000153067565069928,"CTNNB1/MYC/AKT2/CREBBP/CSNK2A1/EP300/GSK3B/AXIN1/LRP5/LRP6/WNT1/TCF7L2/SOX2",13
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","8/91","40/2914",2.24851348622308e-05,0.000265515954224215,0.000164169181748874,"MYC/CREBBP/NOTCH1/HDAC2/EP300/HES1/SNW1/HIF1A",8
"R-HSA-400253","R-HSA-400253","Circadian Clock","9/91","52/2914",2.31097473365764e-05,0.000267206453579165,0.000165214421748331,"CREB1/CREBBP/PPARGC1A/EP300/NR3C1/HIF1A/MEF2C/ATF2/SREBF1",9
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","12/91","94/2914",2.41253396318598e-05,0.000273256397871065,0.000168955117507761,"CCND1/FOXO1/MYC/STAT3/STAT1/TP53/CDKN1A/FOXO3/HIF1A/IRF4/JUNB/SOX2",12
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","12/91","95/2914",2.69115642792669e-05,0.000298718363499863,0.000184698314842969,"AKT2/AKT3/PRKAA1/HDAC2/CDK1/CSNK2A1/PIN1/TP53/EP300/PRKAA2/STK11/TAF1",12
"R-HSA-198323","R-HSA-198323","AKT phosphorylates targets in the cytosol","5/91","13/2914",2.81038169235015e-05,0.000299954199856603,0.000185462435568047,"AKT2/AKT3/GSK3A/CDKN1A/GSK3B",5
"R-HSA-8941856","R-HSA-8941856","RUNX3 regulates NOTCH signaling","5/91","13/2914",2.81038169235015e-05,0.000299954199856603,0.000185462435568047,"CREBBP/NOTCH1/EP300/HES1/SNW1",5
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","18/91","201/2914",3.07346114846822e-05,0.000321843573094314,0.00019899669004978,"FOXO1/MAPK1/MAPK3/NR4A1/AKT2/AKT3/CREB1/GSK3A/HDAC2/CSNK2A1/JUN/TP53/CDKN1A/GSK3B/PTEN/FOXO3/FOXO4/ATF2",18
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","17/91","187/2914",4.36548480612539e-05,0.000448674827296221,0.000277416773254752,"CDK4/MAPK1/MAPK3/RB1/CREBBP/STAT3/E2F1/JUN/TP53/CDKN1A/EP300/GSK3B/NR3C1/AR/SP1/HIF1A/ARNT",17
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","24/91","332/2914",4.5220100773302e-05,0.000456311925985139,0.00028213881056644,"CCND1/FOXO1/MAPK1/MAPK3/MYC/SMAD3/CREB1/MAP3K7/STAT3/CASP1/CASP3/STAT1/JUN/RPS6KA5/TP53/CDKN1A/FOXO3/HIF1A/IRF4/MEF2C/ATF1/ATF2/JUNB/SOX2",24
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","17/91","189/2914",5.01259259721525e-05,0.000496783730616869,0.000307162629077476,"CDK4/MAPK1/MAPK3/RB1/CREBBP/STAT3/E2F1/JUN/TP53/CDKN1A/EP300/GSK3B/NR3C1/AR/SP1/HIF1A/ARNT",17
"R-HSA-69242","R-HSA-69242","S Phase","10/91","71/2914",5.1518719488888e-05,0.000501629637128646,0.000310158865251662,"CCND1/CDK4/MYC/RB1/AKT2/AKT3/CDC25A/E2F1/CDKN1A/GSK3B",10
"R-HSA-195721","R-HSA-195721","Signaling by WNT","16/91","172/2914",5.71968473754411e-05,0.000547314660230514,0.000338406029843808,"CTNNB1/MYC/AKT2/CREBBP/MAP3K7/RHOA/CSNK2A1/EP300/GSK3B/AXIN1/FZD3/LRP5/LRP6/WNT1/TCF7L2/SOX2",16
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","6/91","24/2914",6.72339100213833e-05,0.000632454577319792,0.00039104825454007,"MAPK1/MAPK3/CREB1/RPS6KA5/MEF2C/ATF1",6
"R-HSA-450294","R-HSA-450294","MAP kinase activation","9/91","60/2914",7.55698309689008e-05,0.000698913470047261,0.000432139954927277,"MAPK1/MAPK3/CREB1/MAP3K7/JUN/RPS6KA5/MEF2C/ATF1/ATF2",9
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","8/91","47/2914",7.68175165277169e-05,0.000698913470047261,0.000432139954927277,"CREBBP/PPARGC1A/EP300/SREBF2/SP1/ESRRA/SREBF1/ARNT",8
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","8/91","48/2914",8.98454726376102e-05,0.000804261892159252,0.000497277149063852,"CREBBP/PPARGC1A/EP300/SREBF2/SP1/ESRRA/SREBF1/ARNT",8
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","8/91","49/2914",0.000104656005623023,0.000921969573345679,0.000570056104145456,"MAPK1/MAPK3/AKT2/AKT3/STAT3/CASP3/E2F1/TP53",8
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","9/91","64/2914",0.000127005917596621,0.00110137944165819,0.000680985676587143,"MAPK1/MAPK3/CREB1/MAP3K7/JUN/RPS6KA5/MEF2C/ATF1/ATF2",9
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","7/91","38/2914",0.000131605502904171,0.00112370852479715,0.000694791804805825,"CREB1/CREBBP/PPARGC1A/PRKAA2/ESRRA/MEF2C/ATF2",7
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","4/91","10/2914",0.00016193857212747,0.00133138751247419,0.000823200244792008,"RBL1/CDK1/E2F1/MYBL2",4
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","4/91","10/2914",0.00016193857212747,0.00133138751247419,0.000823200244792008,"MAPK1/MAPK3/JUN/ATF2",4
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","11/91","97/2914",0.000163124956483324,0.00133138751247419,0.000823200244792008,"FOXO1/NR4A1/AKT2/AKT3/CREB1/GSK3A/CDKN1A/GSK3B/PTEN/FOXO3/FOXO4",11
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","19/91","249/2914",0.000166059306211672,0.00133569441952866,0.000825863216247216,"CCND1/CDK4/MAPK1/MAPK3/MYC/RB1/RBL1/AKT2/AKT3/CDC25A/CDK1/CSNK2A1/E2F1/TP53/CDKN1A/EP300/GSK3B/FOXM1/MYBL2",19
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","6/91","28/2914",0.000170118787534347,0.00134879895830804,0.000833965785506723,"SMAD3/SMAD7/SMAD2/SMAD4/TGFBR1/TGFBR2",6
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","7/91","40/2914",0.000184754001896905,0.00144420381764482,0.000892954849790823,"CDK4/CREBBP/PPARGC1A/EP300/WNT1/SREBF2/SREBF1",7
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","5/91","19/2914",0.000218777875006,0.00166331124148397,0.00102842952057615,"CREBBP/RAF1/RPS6KA5/EP300/PAK1",5
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","5/91","19/2914",0.000218777875006,0.00166331124148397,0.00102842952057615,"MAPK1/MAPK3/RB1/HES1/AR",5
"R-HSA-109581","R-HSA-109581","Apoptosis","11/91","101/2914",0.000235091813190611,0.00176318859892959,0.0010901839416805,"CTNNB1/MAPK1/MAPK3/AKT2/AKT3/STAT3/CASP3/CASP6/CDH1/E2F1/TP53",11
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","4/91","11/2914",0.000248415989139168,0.00179100149833333,0.00110738072727675,"MYC/RBL1/CDC25A/E2F1",4
"R-HSA-452723","R-HSA-452723","Transcriptional regulation of pluripotent stem cells","4/91","11/2914",0.000248415989139168,0.00179100149833333,0.00110738072727675,"SMAD2/SMAD4/STAT3/SOX2",4
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","12/91","119/2914",0.000251671526117387,0.00179100149833333,0.00110738072727675,"CREBBP/PPARGC1A/CSNK2A1/EP300/PRKAA2/PTEN/SREBF2/SP1/VDR/ESRRA/SREBF1/ARNT",12
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","6/91","30/2914",0.00025493534841141,0.00179100149833333,0.00110738072727675,"CTNNB1/GSK3B/AXIN1/LRP5/LRP6/WNT1",6
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","6/91","30/2914",0.00025493534841141,0.00179100149833333,0.00110738072727675,"RBL1/CDK1/E2F1/TP53/CDKN1A/EP300",6
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","11/91","103/2914",0.000280173361250162,0.001943702693673,0.00120179626009938,"CTNNB1/MAPK1/MAPK3/AKT2/AKT3/STAT3/CASP3/CASP6/CDH1/E2F1/TP53",11
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","6/91","31/2914",0.000308251924484331,0.00211209651961486,0.00130591458585954,"CTNNB1/GSK3B/AXIN1/LRP5/LRP6/TCF7L2",6
"R-HSA-2151201","R-HSA-2151201","Transcriptional activation of mitochondrial biogenesis","6/91","32/2914",0.000369947449650598,0.00247374499465159,0.0015295227468116,"CREB1/CREBBP/PPARGC1A/ESRRA/MEF2C/ATF2",6
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","6/91","32/2914",0.000369947449650598,0.00247374499465159,0.0015295227468116,"MAPK1/MAPK3/HDAC2/JUN/TP53/ATF2",6
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","7/91","46/2914",0.00045524862257699,0.00296850223640728,0.00183543239273356,"NR4A1/NR3C1/AR/NR2F1/VDR/ESRRA/NR2C2",7
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","5/91","22/2914",0.000459984130326172,0.00296850223640728,0.00183543239273356,"CTNNB1/MYC/CREBBP/EP300/TCF7L2",5
"R-HSA-2173788","R-HSA-2173788","Downregulation of TGF-beta receptor signaling","5/91","22/2914",0.000459984130326172,0.00296850223640728,0.00183543239273356,"SMAD3/SMAD7/SMAD2/TGFBR1/TGFBR2",5
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","6/91","34/2914",0.000522080120339611,0.00333051111251131,0.00205926339057124,"FOXO1/MYC/CDK1/JUN/PAK1/FOXO3",6
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","9/91","78/2914",0.00058652945835249,0.00361693165984036,0.0022363579347709,"MAPK1/MAPK3/CREB1/MAP3K7/JUN/RPS6KA5/MEF2C/ATF1/ATF2",9
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","9/91","78/2914",0.00058652945835249,0.00361693165984036,0.0022363579347709,"MAPK1/MAPK3/CREB1/MAP3K7/JUN/RPS6KA5/MEF2C/ATF1/ATF2",9
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","9/91","78/2914",0.00058652945835249,0.00361693165984036,0.0022363579347709,"MAPK1/MAPK3/CREB1/MAP3K7/JUN/RPS6KA5/MEF2C/ATF1/ATF2",9
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","6/91","35/2914",0.000614434698801774,0.0037473764597251,0.00231701228235255,"AKT2/AKT3/PRKAA1/TP53/PRKAA2/PTEN",6
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","24/91","393/2914",0.000651924625508252,0.00393280616475087,0.00243166393496213,"MYC/SMAD3/SMAD7/CREBBP/MAP3K7/PPARGC1A/RHOA/SMAD2/SMAD4/TGFBR1/TGFBR2/CDC25A/HDAC2/CDK1/TP53/EP300/PTEN/AXIN1/NR3C1/FOXO4/AR/HIF1A/VDR/SMAD1",24
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","8/91","64/2914",0.000699221907938896,0.00413921969890485,0.00255928994185487,"MYC/CREBBP/NOTCH1/HDAC2/EP300/HES1/SNW1/HIF1A",8
"R-HSA-2426168","R-HSA-2426168","Activation of gene expression by SREBF (SREBP)","4/91","14/2914",0.000701057030084785,0.00413921969890485,0.00255928994185487,"CREBBP/SREBF2/SP1/SREBF1",4
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","6/91","37/2914",0.000836845501165977,0.00471799527411554,0.00291714833449344,"CREBBP/NOTCH1/STAT1/EP300/HES1/SNW1",6
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","10/91","99/2914",0.0008442707471523,0.00471799527411554,0.00291714833449344,"CDK4/MAPK1/MAPK3/RB1/STAT3/E2F1/JUN/TP53/CDKN1A/SP1",10
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","5/91","25/2914",0.000861674630844992,0.00471799527411554,0.00291714833449344,"MYC/CREBBP/CDKN1A/EP300/MYBL2",5
"R-HSA-2644602","R-HSA-2644602","Signaling by NOTCH1 PEST Domain Mutants in Cancer","7/91","51/2914",0.000867091023350964,0.00471799527411554,0.00291714833449344,"MYC/CREBBP/NOTCH1/HDAC2/EP300/HES1/SNW1",7
"R-HSA-2644603","R-HSA-2644603","Signaling by NOTCH1 in Cancer","7/91","51/2914",0.000867091023350964,0.00471799527411554,0.00291714833449344,"MYC/CREBBP/NOTCH1/HDAC2/EP300/HES1/SNW1",7
"R-HSA-2644606","R-HSA-2644606","Constitutive Signaling by NOTCH1 PEST Domain Mutants","7/91","51/2914",0.000867091023350964,0.00471799527411554,0.00291714833449344,"MYC/CREBBP/NOTCH1/HDAC2/EP300/HES1/SNW1",7
"R-HSA-2894858","R-HSA-2894858","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","7/91","51/2914",0.000867091023350964,0.00471799527411554,0.00291714833449344,"MYC/CREBBP/NOTCH1/HDAC2/EP300/HES1/SNW1",7
"R-HSA-2894862","R-HSA-2894862","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","7/91","51/2914",0.000867091023350964,0.00471799527411554,0.00291714833449344,"MYC/CREBBP/NOTCH1/HDAC2/EP300/HES1/SNW1",7
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","9/91","83/2914",0.000929557031900482,0.00493314293797116,0.00305017467572992,"MAPK1/MAPK3/CREB1/MAP3K7/JUN/RPS6KA5/MEF2C/ATF1/ATF2",9
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","4/91","15/2914",0.000933297312589139,0.00493314293797116,0.00305017467572992,"SMAD3/SMAD2/SMAD4/FOXO3",4
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","4/91","15/2914",0.000933297312589139,0.00493314293797116,0.00305017467572992,"RBL1/CDK1/TP53/EP300",4
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","9/91","84/2914",0.00101466684033742,0.00526299155502119,0.00325412090457451,"MAPK1/MAPK3/CREB1/MAP3K7/JUN/RPS6KA5/MEF2C/ATF1/ATF2",9
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","9/91","84/2914",0.00101466684033742,0.00526299155502119,0.00325412090457451,"MAPK1/MAPK3/CREB1/MAP3K7/JUN/RPS6KA5/MEF2C/ATF1/ATF2",9
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","5/91","26/2914",0.00104080135327793,0.00534856250990046,0.00330702964101954,"PPARGC1A/STAT1/GSK3B/NR3C1/ESRRA",5
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","8/91","68/2914",0.00105405361015919,0.0053669702168656,0.00331841117249537,"CDC25A/CDK1/E2F1/TP53/CDKN1A/EP300/FOXM1/MYBL2",8
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","9/91","86/2914",0.00120392046439277,0.00596585587266058,0.00368870367849663,"MAPK1/MAPK3/CREB1/MAP3K7/JUN/RPS6KA5/MEF2C/ATF1/ATF2",9
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","9/91","86/2914",0.00120392046439277,0.00596585587266058,0.00368870367849663,"MAPK1/MAPK3/CREB1/MAP3K7/JUN/RPS6KA5/MEF2C/ATF1/ATF2",9
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","9/91","86/2914",0.00120392046439277,0.00596585587266058,0.00368870367849663,"MAPK1/MAPK3/CREB1/MAP3K7/JUN/RPS6KA5/MEF2C/ATF1/ATF2",9
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","8/91","70/2914",0.00127895130806033,0.00610380119251554,0.00377399561642497,"MAPK1/MAPK3/CREB1/RHOA/STAT3/RPS6KA5/MEF2C/ATF1",8
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","6/91","40/2914",0.00128133219331116,0.00610380119251554,0.00377399561642497,"CCND1/CDK4/RB1/RBL1/E2F1/CDKN1A",6
"R-HSA-69236","R-HSA-69236","G1 Phase","6/91","40/2914",0.00128133219331116,0.00610380119251554,0.00377399561642497,"CCND1/CDK4/RB1/RBL1/E2F1/CDKN1A",6
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","6/91","40/2914",0.00128133219331116,0.00610380119251554,0.00377399561642497,"SMAD3/CREBBP/NOTCH1/EP300/HES1/SNW1",6
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","9/91","87/2914",0.00130874295839522,0.00610380119251554,0.00377399561642497,"MAPK1/MAPK3/CREB1/MAP3K7/JUN/RPS6KA5/MEF2C/ATF1/ATF2",9
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","9/91","87/2914",0.00130874295839522,0.00610380119251554,0.00377399561642497,"MAPK1/MAPK3/CREB1/MAP3K7/JUN/RPS6KA5/MEF2C/ATF1/ATF2",9
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","9/91","87/2914",0.00130874295839522,0.00610380119251554,0.00377399561642497,"MAPK1/MAPK3/CREB1/MAP3K7/JUN/RPS6KA5/MEF2C/ATF1/ATF2",9
"R-HSA-8957322","R-HSA-8957322","Metabolism of steroids","5/91","28/2914",0.00148012172283259,0.00684556296810072,0.00423262878634582,"CREBBP/SREBF2/SP1/VDR/SREBF1",5
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","7/91","56/2914",0.00152967853690294,0.00701629411554656,0.00433819228386568,"PRKAA1/CSNK2A1/PIN1/TP53/PRKAA2/STK11/TAF1",7
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","9/91","90/2914",0.00166827856854807,0.00752759841905835,0.00465433301965485,"MAPK1/MAPK3/CREB1/MAP3K7/JUN/RPS6KA5/MEF2C/ATF1/ATF2",9
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","9/91","90/2914",0.00166827856854807,0.00752759841905835,0.00465433301965485,"MAPK1/MAPK3/CREB1/MAP3K7/JUN/RPS6KA5/MEF2C/ATF1/ATF2",9
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","6/91","44/2914",0.00213132802334902,0.00953941171740891,0.005898242237791,"CDK4/MAPK1/MAPK3/E2F1/JUN/TP53",6
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","6/91","45/2914",0.00239831329905914,0.0106485110478226,0.00658400114099604,"CDK4/MAPK1/MAPK3/STAT3/JUN/CDKN1A",6
"R-HSA-1655829","R-HSA-1655829","Regulation of cholesterol biosynthesis by SREBP (SREBF)","4/91","20/2914",0.00293867437040199,0.0128422383903394,0.00794038826979733,"CREBBP/SREBF2/SP1/SREBF1",4
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","4/91","20/2914",0.00293867437040199,0.0128422383903394,0.00794038826979733,"MAPK1/MAPK3/CSNK2A1/PAK1",4
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","6/91","47/2914",0.00300708503971134,0.0128463802750008,0.00794294920749218,"CCND1/CDK4/RHOA/STAT3/NR3C1/HIF1A",6
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","6/91","47/2914",0.00300708503971134,0.0128463802750008,0.00794294920749218,"CCND1/CDK4/RHOA/STAT3/NR3C1/HIF1A",6
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","3/91","10/2914",0.00301569333351353,0.0128463802750008,0.00794294920749218,"AKT2/AKT3/TP53",3
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","8/91","80/2914",0.00304094061299475,0.0128463802750008,0.00794294920749218,"CREB1/CREBBP/PPARGC1A/CDK1/PRKAA2/ESRRA/MEF2C/ATF2",8
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","7/91","63/2914",0.00305535530864883,0.0128463802750008,0.00794294920749218,"CCND1/MAPK1/MAPK3/AKT2/AKT3/CREB1/FOXO3",7
"R-HSA-111465","R-HSA-111465","Apoptotic cleavage of cellular proteins","4/91","21/2914",0.0035443972968318,0.0145714111091974,0.00900954010734632,"CTNNB1/CASP3/CASP6/CDH1",4
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","4/91","21/2914",0.0035443972968318,0.0145714111091974,0.00900954010734632,"MAPK1/MAPK3/RPS6KA5/MEF2C",4
"R-HSA-397795","R-HSA-397795","G-protein beta:gamma signalling","4/91","21/2914",0.0035443972968318,0.0145714111091974,0.00900954010734632,"AKT2/AKT3/RHOA/PAK1",4
"R-HSA-69275","R-HSA-69275","G2/M Transition","7/91","66/2914",0.00398589607472702,0.0157318139678177,0.00972702011096928,"CDC25A/CDK1/TP53/CDKN1A/EP300/FOXM1/MYBL2",7
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","3/91","11/2914",0.00405342233765392,0.0157318139678177,0.00972702011096928,"RB1/CDK1/E2F1",3
"R-HSA-210745","R-HSA-210745","Regulation of gene expression in beta cells","3/91","11/2914",0.00405342233765392,0.0157318139678177,0.00972702011096928,"FOXO1/AKT2/AKT3",3
"R-HSA-2197563","R-HSA-2197563","NOTCH2 intracellular domain regulates transcription","3/91","11/2914",0.00405342233765392,0.0157318139678177,0.00972702011096928,"CREB1/EP300/HES1",3
"R-HSA-5627117","R-HSA-5627117","RHO GTPases Activate ROCKs","3/91","11/2914",0.00405342233765392,0.0157318139678177,0.00972702011096928,"RHOA/ROCK2/PAK1",3
"R-HSA-6803207","R-HSA-6803207","TP53 Regulates Transcription of Caspase Activators and Caspases","3/91","11/2914",0.00405342233765392,0.0157318139678177,0.00972702011096928,"CASP1/CASP6/TP53",3
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","3/91","11/2914",0.00405342233765392,0.0157318139678177,0.00972702011096928,"E2F1/TP53/CDKN1A",3
"R-HSA-75815","R-HSA-75815","Ubiquitin-dependent degradation of Cyclin D","3/91","11/2914",0.00405342233765392,0.0157318139678177,0.00972702011096928,"CCND1/CDK4/GSK3B",3
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","3/91","12/2914",0.00528331014005017,0.0202223250188127,0.0125035143786305,"MAPK1/MAPK3/CASP3",3
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","3/91","12/2914",0.00528331014005017,0.0202223250188127,0.0125035143786305,"SMAD3/SMAD2/SMAD4",3
"R-HSA-1234174","R-HSA-1234174","Cellular response to hypoxia","4/91","24/2914",0.00585819836568808,0.0220794805954557,0.0136517983387739,"CREBBP/EP300/HIF1A/ARNT",4
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","4/91","24/2914",0.00585819836568808,0.0220794805954557,0.0136517983387739,"MAPK1/MAPK3/STAT3/STAT1",4
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","8/91","89/2914",0.00588786149212151,0.0220794805954557,0.0136517983387739,"MAPK1/MAPK3/CREB1/RHOA/STAT3/RPS6KA5/MEF2C/ATF1",8
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","9/91","110/2914",0.00656241385485684,0.0244438905331916,0.0151137189451313,"MAPK1/MAPK3/CREB1/MAP3K7/JUN/RPS6KA5/MEF2C/ATF1/ATF2",9
"R-HSA-1368082","R-HSA-1368082","RORA activates gene expression","3/91","13/2914",0.0067144214877868,0.0248433595048112,0.0153607116141649,"CREBBP/EP300/SREBF1",3
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","4/91","25/2914",0.00680991717232485,0.0248651580963177,0.0153741897380741,"CTNNB1/AKT2/AKT3/PAK1",4
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","4/91","25/2914",0.00680991717232485,0.0248651580963177,0.0153741897380741,"AKT2/AKT3/CSNK2A1/PTEN",4
"R-HSA-350054","R-HSA-350054","Notch-HLH transcription pathway","4/91","26/2914",0.00785884732124249,0.0283224692421401,0.0175118539078951,"CREBBP/NOTCH1/HDAC2/SNW1",4
"R-HSA-75153","R-HSA-75153","Apoptotic execution phase","4/91","26/2914",0.00785884732124249,0.0283224692421401,0.0175118539078951,"CTNNB1/CASP3/CASP6/CDH1",4
"R-HSA-8986944","R-HSA-8986944","Transcriptional Regulation by MECP2","5/91","41/2914",0.00819910831095355,0.028621658251971,0.0176968432245472,"CREB1/HDAC2/PTEN/MEF2C/SOX2",5
"R-HSA-2173791","R-HSA-2173791","TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)","3/91","14/2914",0.00835442997625098,0.028621658251971,0.0176968432245472,"RHOA/TGFBR1/TGFBR2",3
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","3/91","14/2914",0.00835442997625098,0.028621658251971,0.0176968432245472,"CTNNB1/GSK3B/AXIN1",3
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","3/91","14/2914",0.00835442997625098,0.028621658251971,0.0176968432245472,"CTNNB1/GSK3B/AXIN1",3
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","3/91","14/2914",0.00835442997625098,0.028621658251971,0.0176968432245472,"CTNNB1/GSK3B/AXIN1",3
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","3/91","14/2914",0.00835442997625098,0.028621658251971,0.0176968432245472,"CTNNB1/GSK3B/AXIN1",3
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","3/91","14/2914",0.00835442997625098,0.028621658251971,0.0176968432245472,"CTNNB1/GSK3B/AXIN1",3
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","3/91","14/2914",0.00835442997625098,0.028621658251971,0.0176968432245472,"CTNNB1/GSK3B/AXIN1",3
"R-HSA-165159","R-HSA-165159","mTOR signalling","4/91","27/2914",0.00900887422454661,0.0304873487477035,0.0188504043466123,"AKT2/PRKAA1/PRKAA2/STK11",4
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","4/91","27/2914",0.00900887422454661,0.0304873487477035,0.0188504043466123,"RHOA/CDK1/TP53/PTEN",4
"R-HSA-5250913","R-HSA-5250913","Positive epigenetic regulation of rRNA expression","3/91","15/2914",0.0102097131421665,0.0335289396088898,0.0207310276197214,"HDAC2/EP300/GSK3B",3
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","3/91","15/2914",0.0102097131421665,0.0335289396088898,0.0207310276197214,"RBL1/CDK1/E2F1",3
"R-HSA-8862803","R-HSA-8862803","Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models","3/91","15/2914",0.0102097131421665,0.0335289396088898,0.0207310276197214,"CDC25A/JUN/FOXO3",3
"R-HSA-8863678","R-HSA-8863678","Neurodegenerative Diseases","3/91","15/2914",0.0102097131421665,0.0335289396088898,0.0207310276197214,"CDC25A/JUN/FOXO3",3
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","3/91","15/2914",0.0102097131421665,0.0335289396088898,0.0207310276197214,"SMAD3/STAT3/CASP1",3
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","4/91","29/2914",0.0116266679045258,0.0375162830640223,0.0231964120983808,"AKT2/AKT3/E2F1/TP53",4
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","4/91","29/2914",0.0116266679045258,0.0375162830640223,0.0231964120983808,"AKT2/AKT3/CDK1/TP53",4
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","4/91","29/2914",0.0116266679045258,0.0375162830640223,0.0231964120983808,"AKT2/AKT3/CDK1/TP53",4
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","3/91","16/2914",0.0122854425632089,0.0385221504100617,0.0238183424062212,"MAPK1/MAPK3/CASP3",3
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","3/91","16/2914",0.0122854425632089,0.0385221504100617,0.0238183424062212,"CTNNB1/GSK3B/AXIN1",3
"R-HSA-392451","R-HSA-392451","G beta:gamma signalling through PI3Kgamma","3/91","16/2914",0.0122854425632089,0.0385221504100617,0.0238183424062212,"AKT2/AKT3/RHOA",3
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","3/91","16/2914",0.0122854425632089,0.0385221504100617,0.0238183424062212,"MAPK1/MAPK3/PIN1",3
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","3/91","16/2914",0.0122854425632089,0.0385221504100617,0.0238183424062212,"CDK1/TP53/CDKN1A",3
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","4/91","30/2914",0.0131010936548506,0.0406207093767714,0.025115886689099,"MAPK1/MAPK3/JUN/PAK1",4
"R-HSA-5633008","R-HSA-5633008","TP53 Regulates Transcription of Cell Death Genes","4/91","30/2914",0.0131010936548506,0.0406207093767714,0.025115886689099,"CREBBP/CASP1/CASP6/TP53",4
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","5/91","47/2914",0.0144937457182623,0.0446890492979755,0.0276313514862779,"MAPK1/MAPK3/CREB1/PRKAA1/PRKAA2",5
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","4/91","31/2914",0.0146899243004271,0.0450436905344587,0.0278506270540228,"CTNNB1/AKT2/TCF7L2/SOX2",4
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","9/91","127/2914",0.0162029580999085,0.0494101194804903,0.0305504010443619,"MAPK1/MAPK3/CREB1/MAP3K7/JUN/RPS6KA5/MEF2C/ATF1/ATF2",9
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","4/91","32/2914",0.016395903749364,0.0494550357657448,0.0305781728964112,"MAPK1/MAPK3/CREB1/RPS6KA5",4
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","4/91","32/2914",0.016395903749364,0.0494550357657448,0.0305781728964112,"MAPK1/MAPK3/CSK/RAF1",4
"R-HSA-380972","R-HSA-380972","Energy dependent regulation of mTOR by LKB1-AMPK","3/91","18/2914",0.0171134041402196,0.0501934067516853,0.0310347095325735,"PRKAA1/PRKAA2/STK11",3
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","3/91","18/2914",0.0171134041402196,0.0501934067516853,0.0310347095325735,"CDC25A/CDK1/FOXM1",3
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","3/91","18/2914",0.0171134041402196,0.0501934067516853,0.0310347095325735,"MAPK1/MAPK3/CREB1",3
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","5/91","49/2914",0.0171603020804089,0.0501934067516853,0.0310347095325735,"MAPK1/MAPK3/CREBBP/EP300/GSK3B",5
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","5/91","49/2914",0.0171603020804089,0.0501934067516853,0.0310347095325735,"MAPK1/MAPK3/CREB1/PRKAA1/PRKAA2",5
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","8/91","107/2914",0.0171833284375139,0.0501934067516853,0.0310347095325735,"CREBBP/PPARGC1A/HDAC2/TP53/EP300/NR3C1/AR/VDR",8
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","4/91","33/2914",0.0182215373121787,0.0529473989961213,0.0327375098581993,"MAPK1/MAPK3/RB1/CDK1",4
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","9/91","130/2914",0.0186421724062999,0.0538875296119607,0.033318794980558,"CTNNB1/MAPK1/MAPK3/RHOA/ROCK2/CDH1/PIN1/PAK1/AR",9
"R-HSA-2990846","R-HSA-2990846","SUMOylation","8/91","109/2914",0.0190358707481289,0.0547404573327022,0.0338461623337333,"CREBBP/PPARGC1A/HDAC2/TP53/EP300/NR3C1/AR/VDR",8
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","4/91","34/2914",0.0201690910060192,0.0577002345790756,0.0356762000432027,"MAPK1/MAPK3/CSK/RAF1",4
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","3/91","20/2914",0.0228586987918551,0.0650593734845108,0.040226374122239,"SMAD3/SMAD2/SMAD4",3
"R-HSA-373760","R-HSA-373760","L1CAM interactions","5/91","53/2914",0.0234302537938798,0.0661090060960172,0.0408753646037015,"MAPK1/MAPK3/CSNK2A1/RPS6KA5/PAK1",5
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","6/91","72/2914",0.0234657192809286,0.0661090060960172,0.0408753646037015,"CREBBP/MAP3K7/RAF1/RPS6KA5/EP300/PAK1",6
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","4/91","37/2914",0.0267623556211637,0.0750156937865952,0.0463823919856425,"CTNNB1/GSK3B/AXIN1/TCF7L2",4
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","4/91","38/2914",0.0292154919406946,0.0811273218916341,0.0501612270017501,"RHOA/ROCK2/GSK3B/PAK1",4
"R-HSA-187577","R-HSA-187577","SCF(Skp2)-mediated degradation of p27/p21","3/91","22/2914",0.0295274216614596,0.0811273218916341,0.0501612270017501,"CCND1/CDK4/CDKN1A",3
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","3/91","22/2914",0.0295274216614596,0.0811273218916341,0.0501612270017501,"MAPK1/MAPK3/CREB1",3
"R-HSA-525793","R-HSA-525793","Myogenesis","3/91","22/2914",0.0295274216614596,0.0811273218916341,0.0501612270017501,"CTNNB1/TCF4/MEF2C",3
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","6/91","76/2914",0.0297395017836211,0.0813075048764026,0.0502726345940393,"CTNNB1/MAP3K7/RHOA/FZD3/WNT1/TCF7L2",6
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","3/91","23/2914",0.0332065953234466,0.0899007824610383,0.0555858797198644,"MAPK1/MAPK3/CDK1",3
"R-HSA-201451","R-HSA-201451","Signaling by BMP","3/91","23/2914",0.0332065953234466,0.0899007824610383,0.0555858797198644,"SMAD7/SMAD4/SMAD1",3
"R-HSA-4086398","R-HSA-4086398","Ca2+ pathway","4/91","40/2914",0.0345117286132812,0.0929806280600537,0.0574901559935088,"CTNNB1/MAP3K7/FZD3/TCF7L2",4
"R-HSA-202403","R-HSA-202403","TCR signaling","5/91","59/2914",0.0353429322456,0.0944862274856789,0.0584210719020035,"PTPRJ/CSK/MAP3K7/PAK1/PTEN",5
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","2/91","10/2914",0.0368759745472628,0.0944862274856789,0.0584210719020035,"MAPK3/CDK1",2
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","2/91","10/2914",0.0368759745472628,0.0944862274856789,0.0584210719020035,"MAPK1/MAPK3",2
"R-HSA-113501","R-HSA-113501","Inhibition of replication initiation of damaged DNA by RB1/E2F1","2/91","10/2914",0.0368759745472628,0.0944862274856789,0.0584210719020035,"RB1/E2F1",2
"R-HSA-5250924","R-HSA-5250924","B-WICH complex positively regulates rRNA expression","2/91","10/2914",0.0368759745472628,0.0944862274856789,0.0584210719020035,"EP300/GSK3B",2
"R-HSA-74749","R-HSA-74749","Signal attenuation","2/91","10/2914",0.0368759745472628,0.0944862274856789,0.0584210719020035,"MAPK1/MAPK3",2
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","2/91","10/2914",0.0368759745472628,0.0944862274856789,0.0584210719020035,"STAT3/STAT1",2
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","2/91","10/2914",0.0368759745472628,0.0944862274856789,0.0584210719020035,"STAT3/STAT1",2
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","2/91","10/2914",0.0368759745472628,0.0944862274856789,0.0584210719020035,"MAPK1/MAPK3",2
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","3/91","24/2914",0.037113509174555,0.0944862274856789,0.0584210719020035,"RB1/TP53/CDKN1A",3
"R-HSA-5625740","R-HSA-5625740","RHO GTPases activate PKNs","3/91","24/2914",0.037113509174555,0.0944862274856789,0.0584210719020035,"RHOA/PAK1/AR",3
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","3/91","24/2914",0.037113509174555,0.0944862274856789,0.0584210719020035,"CDC25A/TP53/CDKN1A",3
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","4/91","42/2914",0.0403325773308899,0.100831443327225,0.0623443348026083,"MAPK1/MAPK3/CSK/RAF1",4
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","4/91","42/2914",0.0403325773308899,0.100831443327225,0.0623443348026083,"MAPK1/MAPK3/CSK/RAF1",4
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","4/91","42/2914",0.0403325773308899,0.100831443327225,0.0623443348026083,"MAPK1/MAPK3/CSK/RAF1",4
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","4/91","42/2914",0.0403325773308899,0.100831443327225,0.0623443348026083,"MAPK1/MAPK3/CSK/RAF1",4
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","2/91","11/2914",0.044169875038287,0.107992425754402,0.0667719882331628,"STAT3/STAT1",2
"R-HSA-1358803","R-HSA-1358803","Downregulation of ERBB2:ERBB3 signaling","2/91","11/2914",0.044169875038287,0.107992425754402,0.0667719882331628,"AKT2/AKT3",2
"R-HSA-3371568","R-HSA-3371568","Attenuation phase","2/91","11/2914",0.044169875038287,0.107992425754402,0.0667719882331628,"CREBBP/EP300",2
"R-HSA-416572","R-HSA-416572","Sema4D induced cell migration and growth-cone collapse","2/91","11/2914",0.044169875038287,0.107992425754402,0.0667719882331628,"RHOA/ROCK2",2
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","2/91","11/2914",0.044169875038287,0.107992425754402,0.0667719882331628,"STAT3/STAT1",2
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","11/91","202/2914",0.0473666872588939,0.115300488722308,0.0712905819316686,"FOXO1/MAPK1/MAPK3/MYC/CSK/DAB2IP/CDK1/JUN/RAF1/PAK1/FOXO3",11
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","6/91","85/2914",0.0476505630868776,0.115484989140686,0.0714046590040087,"CTNNB1/AKT2/AKT3/RHOA/ROCK2/PAK1",6
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","3/91","27/2914",0.0501746099678201,0.120029778155777,0.0742147134732729,"CREBBP/JUN/EP300",3
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","3/91","27/2914",0.0501746099678201,0.120029778155777,0.0742147134732729,"CREBBP/JUN/EP300",3
"R-HSA-5689603","R-HSA-5689603","UCH proteinases","3/91","27/2914",0.0501746099678201,0.120029778155777,0.0742147134732729,"SMAD7/TGFBR1/TGFBR2",3
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","2/91","12/2914",0.0519471880179344,0.120630499372191,0.0745861409110179,"MAPK1/MAPK3",2
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","2/91","12/2914",0.0519471880179344,0.120630499372191,0.0745861409110179,"STAT3/STAT1",2
"R-HSA-202427","R-HSA-202427","Phosphorylation of CD3 and TCR zeta chains","2/91","12/2914",0.0519471880179344,0.120630499372191,0.0745861409110179,"PTPRJ/CSK",2
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","2/91","12/2914",0.0519471880179344,0.120630499372191,0.0745861409110179,"MAPK1/MAPK3",2
"R-HSA-381771","R-HSA-381771","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","2/91","12/2914",0.0519471880179344,0.120630499372191,0.0745861409110179,"CTNNB1/TCF7L2",2
"R-HSA-418990","R-HSA-418990","Adherens junctions interactions","2/91","12/2914",0.0519471880179344,0.120630499372191,0.0745861409110179,"CTNNB1/CDH1",2
"R-HSA-9022699","R-HSA-9022699","MECP2 regulates neuronal receptors and channels","2/91","12/2914",0.0519471880179344,0.120630499372191,0.0745861409110179,"CREB1/HDAC2",2
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","4/91","46/2914",0.0535551340125276,0.12384624740397,0.0765744460003685,"MAPK1/MAPK3/CSK/RAF1",4
"R-HSA-4090294","R-HSA-4090294","SUMOylation of intracellular receptors","3/91","28/2914",0.0549639232069787,0.12657666962603,0.0782626729219264,"NR3C1/AR/VDR",3
"R-HSA-1980145","R-HSA-1980145","Signaling by NOTCH2","3/91","29/2914",0.059964375741877,0.131996390117842,0.0816136997219845,"CREB1/EP300/HES1",3
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","2/91","13/2914",0.0601713273870521,0.131996390117842,0.0816136997219845,"MAPK1/MAPK3",2
"R-HSA-3772470","R-HSA-3772470","Negative regulation of TCF-dependent signaling by WNT ligand antagonists","2/91","13/2914",0.0601713273870521,0.131996390117842,0.0816136997219845,"LRP5/LRP6",2
"R-HSA-4839735","R-HSA-4839735","AXIN mutants destabilize the destruction complex, activating WNT signaling","2/91","13/2914",0.0601713273870521,0.131996390117842,0.0816136997219845,"GSK3B/AXIN1",2
"R-HSA-4839744","R-HSA-4839744","truncated APC mutants destabilize the destruction complex","2/91","13/2914",0.0601713273870521,0.131996390117842,0.0816136997219845,"GSK3B/AXIN1",2
"R-HSA-4839748","R-HSA-4839748","AMER1 mutants destabilize the destruction complex","2/91","13/2914",0.0601713273870521,0.131996390117842,0.0816136997219845,"GSK3B/AXIN1",2
"R-HSA-5467337","R-HSA-5467337","APC truncation mutants have impaired AXIN binding","2/91","13/2914",0.0601713273870521,0.131996390117842,0.0816136997219845,"GSK3B/AXIN1",2
"R-HSA-5467340","R-HSA-5467340","AXIN missense mutants destabilize the destruction complex","2/91","13/2914",0.0601713273870521,0.131996390117842,0.0816136997219845,"GSK3B/AXIN1",2
"R-HSA-5467348","R-HSA-5467348","Truncations of AMER1 destabilize the destruction complex","2/91","13/2914",0.0601713273870521,0.131996390117842,0.0816136997219845,"GSK3B/AXIN1",2
"R-HSA-5626467","R-HSA-5626467","RHO GTPases activate IQGAPs","2/91","13/2914",0.0601713273870521,0.131996390117842,0.0816136997219845,"CTNNB1/CDH1",2
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","2/91","13/2914",0.0601713273870521,0.131996390117842,0.0816136997219845,"TP53/EP300",2
"R-HSA-8876198","R-HSA-8876198","RAB GEFs exchange GTP for GDP on RABs","2/91","13/2914",0.0601713273870521,0.131996390117842,0.0816136997219845,"AKT2/AKT3",2
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","4/91","49/2914",0.0648449596030136,0.14168878968375,0.0876065347309674,"MAPK1/MAPK3/CSK/RAF1",4
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","3/91","30/2914",0.06517140708488,0.141832547983249,0.0876954208488179,"STAT3/CSNK2A1/TP53",3
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","6/91","92/2914",0.0654218599706519,0.141832547983249,0.0876954208488179,"CTNNB1/AKT2/AKT3/RHOA/ROCK2/PAK1",6
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","16/91","347/2914",0.0678740079134891,0.146314749847943,0.0904667775257074,"CTNNB1/MAPK1/MAPK3/PTPRJ/AKT2/AKT3/CREB1/CSK/RHOA/ROCK2/STAT3/STAT1/RPS6KA5/PAK1/MEF2C/ATF1",16
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","2/91","14/2914",0.0688074769555189,0.146314749847943,0.0904667775257074,"MAPK1/MAPK3",2
"R-HSA-3214858","R-HSA-3214858","RMTs methylate histone arginines","2/91","14/2914",0.0688074769555189,0.146314749847943,0.0904667775257074,"CCND1/CDK4",2
"R-HSA-400508","R-HSA-400508","Incretin synthesis, secretion, and inactivation","2/91","14/2914",0.0688074769555189,0.146314749847943,0.0904667775257074,"CTNNB1/TCF7L2",2
"R-HSA-918233","R-HSA-918233","TRAF3-dependent IRF activation pathway","2/91","14/2914",0.0688074769555189,0.146314749847943,0.0904667775257074,"CREBBP/EP300",2
"R-HSA-389356","R-HSA-389356","CD28 co-stimulation","3/91","31/2914",0.0705801373832143,0.148942875466479,0.0920917542002316,"AKT2/AKT3/PAK1",3
"R-HSA-391251","R-HSA-391251","Protein folding","3/91","31/2914",0.0705801373832143,0.148942875466479,0.0920917542002316,"STAT3/CSNK2A1/TP53",3
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","3/91","32/2914",0.0761854029315436,0.160162494799268,0.0990288730290399,"MAPK1/MAPK3/GSK3B",3
"R-HSA-111447","R-HSA-111447","Activation of BAD and translocation to mitochondria ","2/91","15/2914",0.0778225175421885,0.160563186750612,0.0992766218695107,"AKT2/AKT3",2
"R-HSA-3371497","R-HSA-3371497","HSP90 chaperone cycle for steroid hormone receptors (SHR)","2/91","15/2914",0.0778225175421885,0.160563186750612,0.0992766218695107,"NR3C1/AR",2
"R-HSA-400685","R-HSA-400685","Sema4D in semaphorin signaling","2/91","15/2914",0.0778225175421885,0.160563186750612,0.0992766218695107,"RHOA/ROCK2",2
"R-HSA-6803204","R-HSA-6803204","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","2/91","15/2914",0.0778225175421885,0.160563186750612,0.0992766218695107,"CREBBP/TP53",2
"R-HSA-8876384","R-HSA-8876384","Listeria monocytogenes entry into host cells","2/91","15/2914",0.0778225175421885,0.160563186750612,0.0992766218695107,"CTNNB1/CDH1",2
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","4/91","53/2914",0.0816817396266813,0.167901353677067,0.10381382892124,"AKT2/AKT3/CSK/PAK1",4
"R-HSA-4641263","R-HSA-4641263","Regulation of FZD by ubiquitination","2/91","16/2914",0.0871849568248999,0.17624488543344,0.108972655573829,"LRP5/LRP6",2
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","3/91","34/2914",0.0879636635406539,0.17624488543344,0.108972655573829,"MAPK3/STAT1/PIN1",3
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","3/91","34/2914",0.0879636635406539,0.17624488543344,0.108972655573829,"CTNNB1/CREBBP/EP300",3
"R-HSA-3214847","R-HSA-3214847","HATs acetylate histones","3/91","34/2914",0.0879636635406539,0.17624488543344,0.108972655573829,"CREBBP/EP300/ATF2",3
"R-HSA-3928662","R-HSA-3928662","EPHB-mediated forward signaling","3/91","34/2914",0.0879636635406539,0.17624488543344,0.108972655573829,"RHOA/ROCK2/PAK1",3
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","3/91","34/2914",0.0879636635406539,0.17624488543344,0.108972655573829,"MAPK1/MAPK3/RAF1",3
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","3/91","34/2914",0.0879636635406539,0.17624488543344,0.108972655573829,"JUN/TP53/ATF2",3
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","5/91","77/2914",0.0905222062457796,0.180718793044632,0.111738883892935,"MAPK1/MAPK3/CREB1/PRKAA1/PRKAA2",5
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","3/91","35/2914",0.0941252015132026,0.187238304085403,0.115769913953232,"MAPK3/STAT1/PIN1",3
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","2/91","18/2914",0.106833794055469,0.21051265593584,0.130160504191719,"CSNK2A1/EP300",2
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","3/91","37/2914",0.106963187340373,0.21051265593584,0.130160504191719,"HDAC2/EP300/GSK3B",3
"R-HSA-3899300","R-HSA-3899300","SUMOylation of transcription cofactors","3/91","37/2914",0.106963187340373,0.21051265593584,0.130160504191719,"CREBBP/PPARGC1A/EP300",3
"R-HSA-168249","R-HSA-168249","Innate Immune System","18/91","428/2914",0.109391000151909,0.214530053301446,0.132644471078751,"CTNNB1/MAPK1/MAPK3/PTPRJ/CREB1/CREBBP/MAP3K7/RHOA/CASP1/JUN/PIN1/RAF1/RPS6KA5/EP300/PAK1/MEF2C/ATF1/ATF2",18
"R-HSA-1430728","R-HSA-1430728","Metabolism","13/91","289/2914",0.111036564069989,0.216990468517056,0.134165751989683,"CREBBP/PPARGC1A/CSNK2A1/EP300/PRKAA2/PTEN/STK11/SREBF2/SP1/VDR/ESRRA/SREBF1/ARNT",13
"R-HSA-3371571","R-HSA-3371571","HSF1-dependent transactivation","2/91","19/2914",0.11706474687039,0.226379562763298,0.139971052557298,"CREBBP/EP300",2
"R-HSA-389513","R-HSA-389513","CTLA4 inhibitory signaling","2/91","19/2914",0.11706474687039,0.226379562763298,0.139971052557298,"AKT2/AKT3",2
"R-HSA-421270","R-HSA-421270","Cell-cell junction organization","2/91","19/2914",0.11706474687039,0.226379562763298,0.139971052557298,"CTNNB1/CDH1",2
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","6/91","109/2914",0.122776795227045,0.235782426820104,0.145784867033388,"CCND1/CDK4/CREBBP/HDAC2/EP300/ATF2",6
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","6/91","109/2914",0.122776795227045,0.235782426820104,0.145784867033388,"CCND1/CDK4/CREBBP/HDAC2/EP300/ATF2",6
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","2/91","20/2914",0.127532085545783,0.242398313280513,0.149875486257842,"MAPK1/RPS6KA5",2
"R-HSA-73854","R-HSA-73854","RNA Polymerase I Promoter Clearance","2/91","20/2914",0.127532085545783,0.242398313280513,0.149875486257842,"MAPK3/HDAC2",2
"R-HSA-73864","R-HSA-73864","RNA Polymerase I Transcription","2/91","20/2914",0.127532085545783,0.242398313280513,0.149875486257842,"MAPK3/HDAC2",2
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","5/91","86/2914",0.128856441149926,0.244079606956345,0.150915034362766,"CCND1/CREBBP/CSNK2A1/EP300/AXIN1",5
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","5/91","87/2914",0.133519734962038,0.252052560897725,0.155844731821069,"MAPK1/MAPK3/MAP3K7/JUN/PAK1",5
"R-HSA-389357","R-HSA-389357","CD28 dependent PI3K/Akt signaling","2/91","21/2914",0.138211489388389,0.258362903591225,0.159746432566599,"AKT2/AKT3",2
"R-HSA-3928663","R-HSA-3928663","EPHA-mediated growth cone collapse","2/91","21/2914",0.138211489388389,0.258362903591225,0.159746432566599,"RHOA/ROCK2",2
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","5/91","88/2914",0.138259067327196,0.258362903591225,0.159746432566599,"MAPK1/MAPK3/CREB1/PRKAA1/PRKAA2",5
"R-HSA-909733","R-HSA-909733","Interferon alpha/beta signaling","3/91","42/2914",0.141769326601653,0.264033477395696,0.163252562600279,"STAT1/IRF1/IRF4",3
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","2/91","22/2914",0.149079896161082,0.273184510607095,0.168910669431793,"TP53/CDKN1A",2
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","2/91","22/2914",0.149079896161082,0.273184510607095,0.168910669431793,"TP53/CDKN1A",2
"R-HSA-9022692","R-HSA-9022692","Regulation of MECP2 expression and activity","2/91","22/2914",0.149079896161082,0.273184510607095,0.168910669431793,"CREB1/HDAC2",2
"R-HSA-9024446","R-HSA-9024446","NR1H2 and NR1H3-mediated signaling","2/91","22/2914",0.149079896161082,0.273184510607095,0.168910669431793,"EP300/SREBF1",2
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","3/91","43/2914",0.149143976061171,0.273184510607095,0.168910669431793,"MAPK1/MAPK3/PAK1",3
"R-HSA-1227986","R-HSA-1227986","Signaling by ERBB2","3/91","44/2914",0.156641295140705,0.285035799354398,0.176238351047006,"AKT2/AKT3/RHOA",3
"R-HSA-4086400","R-HSA-4086400","PCP/CE pathway","3/91","44/2914",0.156641295140705,0.285035799354398,0.176238351047006,"RHOA/FZD3/WNT1",3
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","2/91","23/2914",0.160115448621809,0.290405470539556,0.179558432234984,"STAT3/STAT1",2
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","2/91","24/2914",0.171297443117014,0.307670164821822,0.190233236096565,"STAT3/STAT1",2
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","2/91","24/2914",0.171297443117014,0.307670164821822,0.190233236096565,"STAT3/STAT1",2
"R-HSA-8863795","R-HSA-8863795","Downregulation of ERBB2 signaling","2/91","24/2914",0.171297443117014,0.307670164821822,0.190233236096565,"AKT2/AKT3",2
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","3/91","47/2914",0.179804573999173,0.321908188934003,0.199036642185841,"STAT1/IRF1/IRF4",3
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","2/91","25/2914",0.182606280155462,0.323790688454574,0.200200596370206,"MAPK1/MAPK3",2
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","2/91","25/2914",0.182606280155462,0.323790688454574,0.200200596370206,"MAPK1/MAPK3",2
"R-HSA-9007101","R-HSA-9007101","Rab regulation of trafficking","2/91","25/2914",0.182606280155462,0.323790688454574,0.200200596370206,"AKT2/AKT3",2
"R-HSA-913531","R-HSA-913531","Interferon Signaling","5/91","97/2914",0.184081736412065,0.325367400346167,0.201175481295117,"MAPK3/STAT1/PIN1/IRF1/IRF4",5
"R-HSA-111996","R-HSA-111996","Ca-dependent events","2/91","26/2914",0.194023416890945,0.340768975868589,0.210698314145396,"MAPK1/CREB1",2
"R-HSA-1445148","R-HSA-1445148","Translocation of SLC2A4 (GLUT4) to the plasma membrane","2/91","26/2914",0.194023416890945,0.340768975868589,0.210698314145396,"AKT2/PRKAA2",2
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","5/91","99/2914",0.194966335783245,0.341344846560571,0.211054376441434,"MAPK1/MAPK3/AKT2/AKT3/PTEN",5
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","2/91","27/2914",0.205531321444794,0.358710325163084,0.221791495501499,"MAPK1/MAPK3",2
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","2/91","28/2914",0.21711342900155,0.376556103424562,0.232825585047714,"MAPK1/MAPK3",2
"R-HSA-933541","R-HSA-933541","TRAF6 mediated IRF7 activation","2/91","28/2914",0.21711342900155,0.376556103424562,0.232825585047714,"CREBBP/EP300",2
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","3/91","52/2914",0.220266320844684,0.379651577853415,0.234739524666123,"MAPK1/MAPK3/AKT2",3
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","3/91","52/2914",0.220266320844684,0.379651577853415,0.234739524666123,"MAPK1/MAPK3/AKT2",3
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","3/91","53/2914",0.228581395717764,0.389707220020777,0.240956953488427,"PRKAA1/CSNK2A1/PRKAA2",3
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","2/91","29/2914",0.228754099613377,0.389707220020777,0.240956953488427,"STAT3/STAT1",2
"R-HSA-112316","R-HSA-112316","Neuronal System","5/91","105/2914",0.228909105814006,0.389707220020777,0.240956953488427,"MAPK1/MAPK3/CREB1/PRKAA1/PRKAA2",5
"R-HSA-68886","R-HSA-68886","M Phase","5/91","105/2914",0.228909105814006,0.389707220020777,0.240956953488427,"MAPK1/MAPK3/RB1/CDK1/CSNK2A1",5
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","2/91","30/2914",0.240438577651127,0.406839666452364,0.25154998817159,"CSNK2A1/PTEN",2
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","2/91","30/2914",0.240438577651127,0.406839666452364,0.25154998817159,"MAPK1/MAPK3",2
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","2/91","31/2914",0.252152952842017,0.424572868184412,0.262514471366749,"STAT3/STAT1",2
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","4/91","82/2914",0.252448732433975,0.424572868184412,0.262514471366749,"SMAD3/MAP3K7/STAT3/CASP1",4
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","2/91","32/2914",0.263884122836049,0.441131590885564,0.272752771225593,"STAT3/STAT1",2
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","2/91","32/2914",0.263884122836049,0.441131590885564,0.272752771225593,"MAPK1/MAPK3",2
"R-HSA-211945","R-HSA-211945","Phase I - Functionalization of compounds","1/91","10/2914",0.272225830390977,0.449658737699381,0.278025127529632,"ARNT",1
"R-HSA-381038","R-HSA-381038","XBP1(S) activates chaperone genes","1/91","10/2914",0.272225830390977,0.449658737699381,0.278025127529632,"GSK3A",1
"R-HSA-442729","R-HSA-442729","CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde","1/91","10/2914",0.272225830390977,0.449658737699381,0.278025127529632,"CREB1",1
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","1/91","10/2914",0.272225830390977,0.449658737699381,0.278025127529632,"CSNK2A1",1
"R-HSA-168638","R-HSA-168638","NOD1/2 Signaling Pathway","2/91","33/2914",0.275619757245247,0.452570903168971,0.279825726757865,"MAP3K7/CASP1",2
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","2/91","33/2914",0.275619757245247,0.452570903168971,0.279825726757865,"MAPK1/MAPK3",2
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","9/91","228/2914",0.279673138805787,0.457871952912129,0.283103379135806,"CTNNB1/MAPK1/MAPK3/RHOA/ROCK2/CDH1/PIN1/PAK1/AR",9
"R-HSA-112040","R-HSA-112040","G-protein mediated events","2/91","34/2914",0.287348263101784,0.467678258127537,0.289166642294125,"MAPK1/CREB1",2
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","2/91","34/2914",0.287348263101784,0.467678258127537,0.289166642294125,"MAPK1/CREB1",2
"R-HSA-2586552","R-HSA-2586552","Signaling by Leptin","1/91","11/2914",0.295031425926246,0.470524256865133,0.290926330465687,"STAT3",1
"R-HSA-349425","R-HSA-349425","Autodegradation of the E3 ubiquitin ligase COP1","1/91","11/2914",0.295031425926246,0.470524256865133,0.290926330465687,"TP53",1
"R-HSA-69601","R-HSA-69601","Ubiquitin Mediated Degradation of Phosphorylated Cdc25A","1/91","11/2914",0.295031425926246,0.470524256865133,0.290926330465687,"CDC25A",1
"R-HSA-69610","R-HSA-69610","p53-Independent DNA Damage Response","1/91","11/2914",0.295031425926246,0.470524256865133,0.290926330465687,"CDC25A",1
"R-HSA-69613","R-HSA-69613","p53-Independent G1/S DNA damage checkpoint","1/91","11/2914",0.295031425926246,0.470524256865133,0.290926330465687,"CDC25A",1
"R-HSA-75035","R-HSA-75035","Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex","1/91","11/2914",0.295031425926246,0.470524256865133,0.290926330465687,"CDK1",1
"R-HSA-8978868","R-HSA-8978868","Fatty acid metabolism","1/91","11/2914",0.295031425926246,0.470524256865133,0.290926330465687,"PRKAA2",1
"R-HSA-9612973","R-HSA-9612973","Autophagy","3/91","61/2914",0.296801495773066,0.471990917346853,0.29183317032731,"PRKAA1/CSNK2A1/PRKAA2",3
"R-HSA-446728","R-HSA-446728","Cell junction organization","2/91","35/2914",0.29905875168291,0.474221734811472,0.293212490371816,"CTNNB1/CDH1",2
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","3/91","62/2914",0.305460901031956,0.480257224002085,0.296944248505793,"MAPK1/MAPK3/PAK1",3
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","3/91","62/2914",0.305460901031956,0.480257224002085,0.296944248505793,"CDC25A/CDK1/TP53",3
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","3/91","62/2914",0.305460901031956,0.480257224002085,0.296944248505793,"HDAC2/TP53/IRF1",3
"R-HSA-111932","R-HSA-111932","CaMK IV-mediated phosphorylation of CREB","1/91","12/2914",0.317129993008819,0.482211359232589,0.298152495229633,"CREB1",1
"R-HSA-1483206","R-HSA-1483206","Glycerophospholipid biosynthesis","1/91","12/2914",0.317129993008819,0.482211359232589,0.298152495229633,"CSNK2A1",1
"R-HSA-2691230","R-HSA-2691230","Signaling by NOTCH1 HD Domain Mutants in Cancer","1/91","12/2914",0.317129993008819,0.482211359232589,0.298152495229633,"NOTCH1",1
"R-HSA-2691232","R-HSA-2691232","Constitutive Signaling by NOTCH1 HD Domain Mutants","1/91","12/2914",0.317129993008819,0.482211359232589,0.298152495229633,"NOTCH1",1
"R-HSA-3301854","R-HSA-3301854","Nuclear Pore Complex (NPC) Disassembly","1/91","12/2914",0.317129993008819,0.482211359232589,0.298152495229633,"CDK1",1
"R-HSA-381070","R-HSA-381070","IRE1alpha activates chaperones","1/91","12/2914",0.317129993008819,0.482211359232589,0.298152495229633,"GSK3A",1
"R-HSA-389359","R-HSA-389359","CD28 dependent Vav1 pathway","1/91","12/2914",0.317129993008819,0.482211359232589,0.298152495229633,"PAK1",1
"R-HSA-389948","R-HSA-389948","PD-1 signaling","1/91","12/2914",0.317129993008819,0.482211359232589,0.298152495229633,"CSK",1
"R-HSA-399954","R-HSA-399954","Sema3A PAK dependent Axon repulsion","1/91","12/2914",0.317129993008819,0.482211359232589,0.298152495229633,"PAK1",1
"R-HSA-442720","R-HSA-442720","CREB1 phosphorylation through the activation of Adenylate Cyclase","1/91","12/2914",0.317129993008819,0.482211359232589,0.298152495229633,"CREB1",1
"R-HSA-844456","R-HSA-844456","The NLRP3 inflammasome","1/91","12/2914",0.317129993008819,0.482211359232589,0.298152495229633,"CASP1",1
"R-HSA-975163","R-HSA-975163","IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation","1/91","12/2914",0.317129993008819,0.482211359232589,0.298152495229633,"MAP3K7",1
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","2/91","37/2914",0.322385453470268,0.488863187639341,0.302265337449834,"MAPK1/MAPK3",2
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","2/91","38/2914",0.3339831300232,0.50104395841307,0.309796738629988,"MAPK1/MAPK3",2
"R-HSA-111931","R-HSA-111931","PKA-mediated phosphorylation of CREB","1/91","13/2914",0.338543215143966,0.50104395841307,0.309796738629988,"CREB1",1
"R-HSA-3906995","R-HSA-3906995","Diseases associated with O-glycosylation of proteins","1/91","13/2914",0.338543215143966,0.50104395841307,0.309796738629988,"NOTCH1",1
"R-HSA-428540","R-HSA-428540","Activation of RAC1","1/91","13/2914",0.338543215143966,0.50104395841307,0.309796738629988,"PAK1",1
"R-HSA-5689901","R-HSA-5689901","Metalloprotease DUBs","1/91","13/2914",0.338543215143966,0.50104395841307,0.309796738629988,"EP300",1
"R-HSA-6807505","R-HSA-6807505","RNA polymerase II transcribes snRNA genes","1/91","13/2914",0.338543215143966,0.50104395841307,0.309796738629988,"SP1",1
"R-HSA-8964616","R-HSA-8964616","G beta:gamma signalling through CDC42","1/91","13/2914",0.338543215143966,0.50104395841307,0.309796738629988,"PAK1",1
"R-HSA-912446","R-HSA-912446","Meiotic recombination","1/91","13/2914",0.338543215143966,0.50104395841307,0.309796738629988,"CDK4",1
"R-HSA-937072","R-HSA-937072","TRAF6-mediated induction of TAK1 complex within TLR4 complex","1/91","13/2914",0.338543215143966,0.50104395841307,0.309796738629988,"MAP3K7",1
"R-HSA-168928","R-HSA-168928","DDX58/IFIH1-mediated induction of interferon-alpha/beta","3/91","66/2914",0.340177973473341,0.50212440233432,0.310464779821694,"CREBBP/PIN1/EP300",3
"R-HSA-2682334","R-HSA-2682334","EPH-Ephrin signaling","3/91","68/2914",0.357522051785927,0.517940585805856,0.320243965808836,"RHOA/ROCK2/PAK1",3
"R-HSA-211859","R-HSA-211859","Biological oxidations","1/91","14/2914",0.359292118081539,0.517940585805856,0.320243965808836,"ARNT",1
"R-HSA-445355","R-HSA-445355","Smooth Muscle Contraction","1/91","14/2914",0.359292118081539,0.517940585805856,0.320243965808836,"PAK1",1
"R-HSA-4641257","R-HSA-4641257","Degradation of AXIN","1/91","14/2914",0.359292118081539,0.517940585805856,0.320243965808836,"AXIN1",1
"R-HSA-6785631","R-HSA-6785631","ERBB2 Regulates Cell Motility","1/91","14/2914",0.359292118081539,0.517940585805856,0.320243965808836,"RHOA",1
"R-HSA-68867","R-HSA-68867","Assembly of the pre-replicative complex","1/91","14/2914",0.359292118081539,0.517940585805856,0.320243965808836,"E2F1",1
"R-HSA-877312","R-HSA-877312","Regulation of IFNG signaling","1/91","14/2914",0.359292118081539,0.517940585805856,0.320243965808836,"STAT1",1
"R-HSA-8849471","R-HSA-8849471","PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases","1/91","14/2914",0.359292118081539,0.517940585805856,0.320243965808836,"RHOA",1
"R-HSA-8983432","R-HSA-8983432","Interleukin-15 signaling","1/91","14/2914",0.359292118081539,0.517940585805856,0.320243965808836,"STAT3",1
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","2/91","41/2914",0.368414519193792,0.526984685960192,0.325835955662442,"STAT3/STAT1",2
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","2/91","41/2914",0.368414519193792,0.526984685960192,0.325835955662442,"STAT3/STAT1",2
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","2/91","41/2914",0.368414519193792,0.526984685960192,0.325835955662442,"MAPK1/MAPK3",2
"R-HSA-1474228","R-HSA-1474228","Degradation of the extracellular matrix","3/91","70/2914",0.374812368725585,0.532220864260066,0.329073497863976,"CAPN3/CASP3/CDH1",3
"R-HSA-1660499","R-HSA-1660499","Synthesis of PIPs at the plasma membrane","1/91","15/2914",0.379397089548636,0.532220864260066,0.329073497863976,"PTEN",1
"R-HSA-176412","R-HSA-176412","Phosphorylation of the APC/C","1/91","15/2914",0.379397089548636,0.532220864260066,0.329073497863976,"CDK1",1
"R-HSA-2028269","R-HSA-2028269","Signaling by Hippo","1/91","15/2914",0.379397089548636,0.532220864260066,0.329073497863976,"CASP3",1
"R-HSA-392517","R-HSA-392517","Rap1 signalling","1/91","15/2914",0.379397089548636,0.532220864260066,0.329073497863976,"RAF1",1
"R-HSA-427413","R-HSA-427413","NoRC negatively regulates rRNA expression","1/91","15/2914",0.379397089548636,0.532220864260066,0.329073497863976,"HDAC2",1
"R-HSA-69541","R-HSA-69541","Stabilization of p53","1/91","15/2914",0.379397089548636,0.532220864260066,0.329073497863976,"TP53",1
"R-HSA-2980736","R-HSA-2980736","Peptide hormone metabolism","2/91","42/2914",0.379746778823399,0.532220864260066,0.329073497863976,"CTNNB1/TCF7L2",2
"R-HSA-202424","R-HSA-202424","Downstream TCR signaling","2/91","43/2914",0.390995696031312,0.543924406904844,0.336309827692706,"MAP3K7/PTEN",2
"R-HSA-422475","R-HSA-422475","Axon guidance","9/91","254/2914",0.397056740388966,0.543924406904844,0.336309827692706,"MAPK1/MAPK3/CREB1/RHOA/ROCK2/CSNK2A1/RPS6KA5/GSK3B/PAK1",9
"R-HSA-176187","R-HSA-176187","Activation of ATR in response to replication stress","1/91","16/2914",0.398877898396885,0.543924406904844,0.336309827692706,"CDC25A",1
"R-HSA-3214815","R-HSA-3214815","HDACs deacetylate histones","1/91","16/2914",0.398877898396885,0.543924406904844,0.336309827692706,"HDAC2",1
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","1/91","16/2914",0.398877898396885,0.543924406904844,0.336309827692706,"TP53",1
"R-HSA-3928664","R-HSA-3928664","Ephrin signaling","1/91","16/2914",0.398877898396885,0.543924406904844,0.336309827692706,"PAK1",1
"R-HSA-5205647","R-HSA-5205647","Mitophagy","1/91","16/2914",0.398877898396885,0.543924406904844,0.336309827692706,"CSNK2A1",1
"R-HSA-5627123","R-HSA-5627123","RHO GTPases activate PAKs","1/91","16/2914",0.398877898396885,0.543924406904844,0.336309827692706,"PAK1",1
"R-HSA-622312","R-HSA-622312","Inflammasomes","1/91","16/2914",0.398877898396885,0.543924406904844,0.336309827692706,"CASP1",1
"R-HSA-6807004","R-HSA-6807004","Negative regulation of MET activity","1/91","16/2914",0.398877898396885,0.543924406904844,0.336309827692706,"PTPRJ",1
"R-HSA-8941858","R-HSA-8941858","Regulation of RUNX3 expression and activity","1/91","16/2914",0.398877898396885,0.543924406904844,0.336309827692706,"EP300",1
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","2/91","45/2914",0.413220574977021,0.556003143443036,0.34377814084861,"STAT3/STAT1",2
"R-HSA-167161","R-HSA-167161","HIV Transcription Initiation","1/91","17/2914",0.417753713181524,0.556003143443036,0.34377814084861,"TAF1",1
"R-HSA-167162","R-HSA-167162","RNA Polymerase II HIV Promoter Escape","1/91","17/2914",0.417753713181524,0.556003143443036,0.34377814084861,"TAF1",1
"R-HSA-174048","R-HSA-174048","APC/C:Cdc20 mediated degradation of Cyclin B","1/91","17/2914",0.417753713181524,0.556003143443036,0.34377814084861,"CDK1",1
"R-HSA-180292","R-HSA-180292","GAB1 signalosome","1/91","17/2914",0.417753713181524,0.556003143443036,0.34377814084861,"CSK",1
"R-HSA-5250941","R-HSA-5250941","Negative epigenetic regulation of rRNA expression","1/91","17/2914",0.417753713181524,0.556003143443036,0.34377814084861,"HDAC2",1
"R-HSA-73776","R-HSA-73776","RNA Polymerase II Promoter Escape","1/91","17/2914",0.417753713181524,0.556003143443036,0.34377814084861,"TAF1",1
"R-HSA-73779","R-HSA-73779","RNA Polymerase II Transcription Pre-Initiation And Promoter Opening","1/91","17/2914",0.417753713181524,0.556003143443036,0.34377814084861,"TAF1",1
"R-HSA-75953","R-HSA-75953","RNA Polymerase II Transcription Initiation","1/91","17/2914",0.417753713181524,0.556003143443036,0.34377814084861,"TAF1",1
"R-HSA-76042","R-HSA-76042","RNA Polymerase II Transcription Initiation And Promoter Clearance","1/91","17/2914",0.417753713181524,0.556003143443036,0.34377814084861,"TAF1",1
"R-HSA-73887","R-HSA-73887","Death Receptor Signalling","4/91","106/2914",0.424145951259008,0.5618694762144,0.34740530914347,"MAP3K7/RHOA/CASP3/HDAC2",4
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","2/91","46/2914",0.424186145106007,0.5618694762144,0.34740530914347,"CDK1/TP53",2
"R-HSA-193704","R-HSA-193704","p75 NTR receptor-mediated signalling","3/91","76/2914",0.426067073717708,0.563017204555543,0.348114952461085,"RHOA/CASP3/HDAC2",3
"R-HSA-1234176","R-HSA-1234176","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","1/91","18/2914",0.436043120188939,0.566753938418879,0.350425384399345,"HIF1A",1
"R-HSA-1483255","R-HSA-1483255","PI Metabolism","1/91","18/2914",0.436043120188939,0.566753938418879,0.350425384399345,"PTEN",1
"R-HSA-202433","R-HSA-202433","Generation of second messenger molecules","1/91","18/2914",0.436043120188939,0.566753938418879,0.350425384399345,"PAK1",1
"R-HSA-449836","R-HSA-449836","Other interleukin signaling","1/91","18/2914",0.436043120188939,0.566753938418879,0.350425384399345,"CASP3",1
"R-HSA-5610783","R-HSA-5610783","Degradation of GLI2 by the proteasome","1/91","18/2914",0.436043120188939,0.566753938418879,0.350425384399345,"GSK3B",1
"R-HSA-5658442","R-HSA-5658442","Regulation of RAS by GAPs","1/91","18/2914",0.436043120188939,0.566753938418879,0.350425384399345,"DAB2IP",1
"R-HSA-8953750","R-HSA-8953750","Transcriptional Regulation by E2F6","1/91","18/2914",0.436043120188939,0.566753938418879,0.350425384399345,"E2F1",1
"R-HSA-168643","R-HSA-168643","Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways","2/91","48/2914",0.445800569641694,0.578082514371822,0.357429871380207,"MAP3K7/CASP1",2
"R-HSA-1368108","R-HSA-1368108","BMAL1:CLOCK,NPAS2 activates circadian gene expression","1/91","19/2914",0.453764140928859,0.58027441985142,0.358785132046587,"CREBBP",1
"R-HSA-2980766","R-HSA-2980766","Nuclear Envelope Breakdown","1/91","19/2914",0.453764140928859,0.58027441985142,0.358785132046587,"CDK1",1
"R-HSA-5610785","R-HSA-5610785","GLI3 is processed to GLI3R by the proteasome","1/91","19/2914",0.453764140928859,0.58027441985142,0.358785132046587,"GSK3B",1
"R-HSA-6814122","R-HSA-6814122","Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding","1/91","19/2914",0.453764140928859,0.58027441985142,0.358785132046587,"CSNK2A1",1
"R-HSA-73762","R-HSA-73762","RNA Polymerase I Transcription Initiation","1/91","19/2914",0.453764140928859,0.58027441985142,0.358785132046587,"HDAC2",1
"R-HSA-9029569","R-HSA-9029569","NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux","1/91","19/2914",0.453764140928859,0.58027441985142,0.358785132046587,"EP300",1
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","2/91","49/2914",0.456441352534694,0.582356208406334,0.360072307141707,"STAT3/STAT1",2
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","2/91","50/2914",0.466966380546893,0.594418213769554,0.36753027537008,"MAPK1/MAPK3",2
"R-HSA-450321","R-HSA-450321","JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1","1/91","20/2914",0.470934249106915,0.595372456160223,0.368120285838279,"MAP3K7",1
"R-HSA-4608870","R-HSA-4608870","Asymmetric localization of PCP proteins","1/91","20/2914",0.470934249106915,0.595372456160223,0.368120285838279,"FZD3",1
"R-HSA-8936459","R-HSA-8936459","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","1/91","20/2914",0.470934249106915,0.595372456160223,0.368120285838279,"EP300",1
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","6/91","177/2914",0.479902465396412,0.604659191343052,0.373862297539753,"MAPK1/MAPK3/CSK/DAB2IP/CDK1/RAF1",6
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","4/91","114/2914",0.480458925013128,0.604659191343052,0.373862297539753,"CDC25A/CDK1/TP53/CDKN1A",4
"R-HSA-3238698","R-HSA-3238698","WNT ligand biogenesis and trafficking","1/91","21/2914",0.487570387092841,0.609462983866052,0.376832494528844,"WNT1",1
"R-HSA-3781865","R-HSA-3781865","Diseases of glycosylation","1/91","21/2914",0.487570387092841,0.609462983866052,0.376832494528844,"NOTCH1",1
"R-HSA-450302","R-HSA-450302","activated TAK1 mediates p38 MAPK activation","1/91","21/2914",0.487570387092841,0.609462983866052,0.376832494528844,"MAP3K7",1
"R-HSA-1266695","R-HSA-1266695","Interleukin-7 signaling","1/91","22/2914",0.503688981899116,0.623989698558056,0.385814398729116,"STAT3",1
"R-HSA-1500620","R-HSA-1500620","Meiosis","1/91","22/2914",0.503688981899116,0.623989698558056,0.385814398729116,"CDK4",1
"R-HSA-167172","R-HSA-167172","Transcription of the HIV genome","1/91","22/2914",0.503688981899116,0.623989698558056,0.385814398729116,"TAF1",1
"R-HSA-5357956","R-HSA-5357956","TNFR1-induced NFkappaB signaling pathway","1/91","22/2914",0.503688981899116,0.623989698558056,0.385814398729116,"MAP3K7",1
"R-HSA-163685","R-HSA-163685","Integration of energy metabolism","2/91","55/2914",0.517753851912492,0.636235779646509,0.39338618144099,"PRKAA2/STK11",2
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","2/91","55/2914",0.517753851912492,0.636235779646509,0.39338618144099,"MAPK1/MAPK3",2
"R-HSA-4551638","R-HSA-4551638","SUMOylation of chromatin organization proteins","1/91","23/2914",0.519305960684448,0.636235779646509,0.39338618144099,"HDAC2",1
"R-HSA-5357769","R-HSA-5357769","Caspase activation via extrinsic apoptotic signalling pathway","1/91","23/2914",0.519305960684448,0.636235779646509,0.39338618144099,"CASP3",1
"R-HSA-69002","R-HSA-69002","DNA Replication Pre-Initiation","1/91","23/2914",0.519305960684448,0.636235779646509,0.39338618144099,"E2F1",1
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","5/91","153/2914",0.525726215108506,0.642682928161279,0.39737246956961,"MAPK1/MAPK3/CSK/RHOA/RAF1",5
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","2/91","56/2914",0.527527499310799,0.643467609049436,0.397857639734691,"CDK1/CSNK2A1",2
"R-HSA-1169091","R-HSA-1169091","Activation of NF-kappaB in B cells","1/91","24/2914",0.534436765796075,0.647625338464676,0.400428374280672,"MAP3K7",1
"R-HSA-1474165","R-HSA-1474165","Reproduction","1/91","24/2914",0.534436765796075,0.647625338464676,0.400428374280672,"CDK4",1
"R-HSA-912694","R-HSA-912694","Regulation of IFNA signaling","1/91","24/2914",0.534436765796075,0.647625338464676,0.400428374280672,"STAT1",1
"R-HSA-1500931","R-HSA-1500931","Cell-Cell communication","2/91","57/2914",0.537168957801613,0.649518020871231,0.40159862456903,"CTNNB1/CDH1",2
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","6/91","188/2914",0.540326599772077,0.651915788855441,0.403081170539353,"MAPK1/MAPK3/AKT2/CSK/DAB2IP/RAF1",6
"R-HSA-111933","R-HSA-111933","Calmodulin induced events","1/91","25/2914",0.549096369364434,0.653966706002706,0.404349257765542,"CREB1",1
"R-HSA-111997","R-HSA-111997","CaM pathway","1/91","25/2914",0.549096369364434,0.653966706002706,0.404349257765542,"CREB1",1
"R-HSA-354192","R-HSA-354192","Integrin alphaIIb beta3 signaling","1/91","25/2914",0.549096369364434,0.653966706002706,0.404349257765542,"CSK",1
"R-HSA-380259","R-HSA-380259","Loss of Nlp from mitotic centrosomes","1/91","25/2914",0.549096369364434,0.653966706002706,0.404349257765542,"CDK1",1
"R-HSA-380284","R-HSA-380284","Loss of proteins required for interphase microtubule organization from the centrosome","1/91","25/2914",0.549096369364434,0.653966706002706,0.404349257765542,"CDK1",1
"R-HSA-9006921","R-HSA-9006921","Integrin signaling","1/91","25/2914",0.549096369364434,0.653966706002706,0.404349257765542,"CSK",1
"R-HSA-111885","R-HSA-111885","Opioid Signalling","2/91","59/2914",0.556050110378599,0.66083043096386,0.408593116157835,"MAPK1/CREB1",2
"R-HSA-380320","R-HSA-380320","Recruitment of NuMA to mitotic centrosomes","1/91","26/2914",0.563299287463374,0.663760306883593,0.410404665801899,"CDK1",1
"R-HSA-674695","R-HSA-674695","RNA Polymerase II Pre-transcription Events","1/91","26/2914",0.563299287463374,0.663760306883593,0.410404665801899,"TAF1",1
"R-HSA-8854518","R-HSA-8854518","AURKA Activation by TPX2","1/91","26/2914",0.563299287463374,0.663760306883593,0.410404665801899,"CDK1",1
"R-HSA-936440","R-HSA-936440","Negative regulators of DDX58/IFIH1 signaling","1/91","26/2914",0.563299287463374,0.663760306883593,0.410404665801899,"PIN1",1
"R-HSA-416482","R-HSA-416482","G alpha (12/13) signalling events","2/91","61/2914",0.57438894749906,0.670016892439395,0.414273128374097,"RHOA/ROCK2",2
"R-HSA-174184","R-HSA-174184","Cdc20:Phospho-APC/C mediated degradation of Cyclin A","1/91","27/2914",0.577059593848704,0.670016892439395,0.414273128374097,"CDK1",1
"R-HSA-2122948","R-HSA-2122948","Activated NOTCH1 Transmits Signal to the Nucleus","1/91","27/2914",0.577059593848704,0.670016892439395,0.414273128374097,"NOTCH1",1
"R-HSA-380270","R-HSA-380270","Recruitment of mitotic centrosome proteins and complexes","1/91","27/2914",0.577059593848704,0.670016892439395,0.414273128374097,"CDK1",1
"R-HSA-380287","R-HSA-380287","Centrosome maturation","1/91","27/2914",0.577059593848704,0.670016892439395,0.414273128374097,"CDK1",1
"R-HSA-445989","R-HSA-445989","TAK1 activates NFkB by phosphorylation and activation of IKKs complex","1/91","27/2914",0.577059593848704,0.670016892439395,0.414273128374097,"MAP3K7",1
"R-HSA-75893","R-HSA-75893","TNF signaling","1/91","27/2914",0.577059593848704,0.670016892439395,0.414273128374097,"MAP3K7",1
"R-HSA-6806834","R-HSA-6806834","Signaling by MET","2/91","62/2914",0.58335321571463,0.675910302132818,0.417917038397911,"PTPRJ/STAT3",2
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","9/91","296/2914",0.587028798448625,0.676997867716023,0.418589482931102,"PTPRJ/AKT2/AKT3/CSK/MAP3K7/CDH1/RAF1/PAK1/PTEN",9
"R-HSA-114604","R-HSA-114604","GPVI-mediated activation cascade","1/91","28/2914",0.590390933287487,0.676997867716023,0.418589482931102,"RHOA",1
"R-HSA-179419","R-HSA-179419","APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint","1/91","28/2914",0.590390933287487,0.676997867716023,0.418589482931102,"CDK1",1
"R-HSA-5620912","R-HSA-5620912","Anchoring of the basal body to the plasma membrane","1/91","28/2914",0.590390933287487,0.676997867716023,0.418589482931102,"CDK1",1
"R-HSA-6781823","R-HSA-6781823","Formation of TC-NER Pre-Incision Complex","1/91","28/2914",0.590390933287487,0.676997867716023,0.418589482931102,"EP300",1
"R-HSA-376176","R-HSA-376176","Signaling by ROBO receptors","2/91","64/2914",0.60086938445621,0.686137554594312,0.424240574296341,"RHOA/PAK1",2
"R-HSA-176409","R-HSA-176409","APC/C:Cdc20 mediated degradation of mitotic proteins","1/91","29/2914",0.603306534490134,0.686137554594312,0.424240574296341,"CDK1",1
"R-HSA-381119","R-HSA-381119","Unfolded Protein Response (UPR)","1/91","29/2914",0.603306534490134,0.686137554594312,0.424240574296341,"GSK3A",1
"R-HSA-5673000","R-HSA-5673000","RAF activation","1/91","29/2914",0.603306534490134,0.686137554594312,0.424240574296341,"RAF1",1
"R-HSA-373080","R-HSA-373080","Class B/2 (Secretin family receptors)","2/91","65/2914",0.609420924794147,0.691674055747959,0.427663806873086,"FZD3/WNT1",2
"R-HSA-1489509","R-HSA-1489509","DAG and IP3 signaling","1/91","30/2914",0.615819222656996,0.696088938033876,0.430393539685241,"CREB1",1
"R-HSA-176814","R-HSA-176814","Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins","1/91","30/2914",0.615819222656996,0.696088938033876,0.430393539685241,"CDK1",1
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","5/91","171/2914",0.627033330082491,0.707324183324761,0.437340320083209,"MAPK1/MAPK3/CSK/DAB2IP/RAF1",5
"R-HSA-6782135","R-HSA-6782135","Dual incision in TC-NER","1/91","32/2914",0.639685215806145,0.720132443757425,0.445259699696388,"EP300",1
"R-HSA-6782210","R-HSA-6782210","Gap-filling DNA repair synthesis and ligation in TC-NER","1/91","33/2914",0.651062261386173,0.727041358288382,0.449531498913253,"EP300",1
"R-HSA-72163","R-HSA-72163","mRNA Splicing - Major Pathway","1/91","33/2914",0.651062261386173,0.727041358288382,0.449531498913253,"SNW1",1
"R-HSA-72172","R-HSA-72172","mRNA Splicing","1/91","33/2914",0.651062261386173,0.727041358288382,0.449531498913253,"SNW1",1
"R-HSA-76009","R-HSA-76009","Platelet Aggregation (Plug Formation)","1/91","33/2914",0.651062261386173,0.727041358288382,0.449531498913253,"CSK",1
"R-HSA-176408","R-HSA-176408","Regulation of APC/C activators between G1/S and early anaphase","1/91","34/2914",0.662083897697821,0.733446233976628,0.453491649647,"CDK1",1
"R-HSA-2500257","R-HSA-2500257","Resolution of Sister Chromatid Cohesion","1/91","34/2914",0.662083897697821,0.733446233976628,0.453491649647,"CDK1",1
"R-HSA-2672351","R-HSA-2672351","Stimuli-sensing channels","1/91","34/2914",0.662083897697821,0.733446233976628,0.453491649647,"RAF1",1
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","1/91","34/2914",0.662083897697821,0.733446233976628,0.453491649647,"TP53",1
"R-HSA-199991","R-HSA-199991","Membrane Trafficking","4/91","144/2914",0.667560337346544,0.738039815193888,0.456331872457482,"AKT2/AKT3/DAB2/PRKAA2",4
"R-HSA-373752","R-HSA-373752","Netrin-1 signaling","1/91","35/2914",0.67276110787473,0.739371118555396,0.45715502067152,"PAK1",1
"R-HSA-5610787","R-HSA-5610787","Hedgehog 'off' state","1/91","35/2914",0.67276110787473,0.739371118555396,0.45715502067152,"GSK3B",1
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","1/91","35/2914",0.67276110787473,0.739371118555396,0.45715502067152,"TP53",1
"R-HSA-2565942","R-HSA-2565942","Regulation of PLK1 Activity at G2/M Transition","1/91","37/2914",0.693124513945667,0.760245267272422,0.470061559280815,"CDK1",1
"R-HSA-2871837","R-HSA-2871837","FCERI mediated NF-kB activation","1/91","38/2914",0.702831037835464,0.769371254435271,0.475704180077569,"MAP3K7",1
"R-HSA-1168372","R-HSA-1168372","Downstream signaling events of B Cell Receptor (BCR)","1/91","39/2914",0.712233810977666,0.775077970769812,0.479232657128419,"MAP3K7",1
"R-HSA-6781827","R-HSA-6781827","Transcription-Coupled Nucleotide Excision Repair (TC-NER)","1/91","39/2914",0.712233810977666,0.775077970769812,0.479232657128419,"EP300",1
"R-HSA-983712","R-HSA-983712","Ion channel transport","1/91","39/2914",0.712233810977666,0.775077970769812,0.479232657128419,"RAF1",1
"R-HSA-174143","R-HSA-174143","APC/C-mediated degradation of cell cycle proteins","1/91","40/2914",0.721342236438894,0.781923713327317,0.483465396955344,"CDK1",1
"R-HSA-453276","R-HSA-453276","Regulation of mitotic cell cycle","1/91","40/2914",0.721342236438894,0.781923713327317,0.483465396955344,"CDK1",1
"R-HSA-109582","R-HSA-109582","Hemostasis","8/91","298/2914",0.728267837266512,0.787892104645057,0.487155668305905,"MAPK1/MAPK3/CSK/RHOA/HDAC2/RAF1/TP53/IRF1",8
"R-HSA-109704","R-HSA-109704","PI3K Cascade","1/91","42/2914",0.738712225724818,0.791477384705162,0.489372455977018,"AKT2",1
"R-HSA-162599","R-HSA-162599","Late Phase of HIV Life Cycle","1/91","42/2914",0.738712225724818,0.791477384705162,0.489372455977018,"TAF1",1
"R-HSA-5617833","R-HSA-5617833","Cilium Assembly","1/91","42/2914",0.738712225724818,0.791477384705162,0.489372455977018,"CDK1",1
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","1/91","42/2914",0.738712225724818,0.791477384705162,0.489372455977018,"STAT3",1
"R-HSA-72203","R-HSA-72203","Processing of Capped Intron-Containing Pre-mRNA","1/91","42/2914",0.738712225724818,0.791477384705162,0.489372455977018,"SNW1",1
"R-HSA-5653656","R-HSA-5653656","Vesicle-mediated transport","4/91","160/2914",0.746798951277293,0.798600034602886,0.49377640830828,"AKT2/AKT3/DAB2/PRKAA2",4
"R-HSA-177929","R-HSA-177929","Signaling by EGFR","1/91","44/2914",0.755010627027066,0.805828650000041,0.498245879374136,"CSK",1
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","3/91","125/2914",0.758398110717341,0.807890501819816,0.499520727535818,"MAPK1/PTPRJ/RHOA",3
"R-HSA-5663205","R-HSA-5663205","Infectious disease","3/91","126/2914",0.763220696021434,0.811470280252675,0.501734113536978,"CTNNB1/CDH1/TAF1",3
"R-HSA-112399","R-HSA-112399","IRS-mediated signalling","1/91","46/2914",0.770302859147686,0.815874211501843,0.504457075295592,"AKT2",1
"R-HSA-198933","R-HSA-198933","Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell","1/91","46/2914",0.770302859147686,0.815874211501843,0.504457075295592,"CDH1",1
"R-HSA-5663220","R-HSA-5663220","RHO GTPases Activate Formins","1/91","47/2914",0.77759101807989,0.822024790541598,0.50825999377252,"RHOA",1
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","2/91","92/2914",0.790679224919301,0.834271805760859,0.51583235405982,"MAPK1/MAPK3",2
"R-HSA-2428928","R-HSA-2428928","IRS-related events triggered by IGF1R","1/91","50/2914",0.798110969366068,0.8405153472451,0.519692751449791,"AKT2",1
"R-HSA-2404192","R-HSA-2404192","Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)","1/91","51/2914",0.804525739543333,0.840888484833427,0.519923463358364,"AKT2",1
"R-HSA-2428924","R-HSA-2428924","IGF1R signaling cascade","1/91","51/2914",0.804525739543333,0.840888484833427,0.519923463358364,"AKT2",1
"R-HSA-69306","R-HSA-69306","DNA Replication","1/91","51/2914",0.804525739543333,0.840888484833427,0.519923463358364,"E2F1",1
"R-HSA-8951664","R-HSA-8951664","Neddylation","1/91","51/2914",0.804525739543333,0.840888484833427,0.519923463358364,"HIF1A",1
"R-HSA-162587","R-HSA-162587","HIV Life Cycle","1/91","53/2914",0.816756595070669,0.847289551895741,0.523881259209126,"TAF1",1
"R-HSA-397014","R-HSA-397014","Muscle contraction","1/91","53/2914",0.816756595070669,0.847289551895741,0.523881259209126,"PAK1",1
"R-HSA-5607764","R-HSA-5607764","CLEC7A (Dectin-1) signaling","1/91","53/2914",0.816756595070669,0.847289551895741,0.523881259209126,"MAP3K7",1
"R-HSA-8856825","R-HSA-8856825","Cargo recognition for clathrin-mediated endocytosis","1/91","53/2914",0.816756595070669,0.847289551895741,0.523881259209126,"DAB2",1
"R-HSA-5358351","R-HSA-5358351","Signaling by Hedgehog","1/91","55/2914",0.828230050932041,0.855991952080601,0.529261975112899,"GSK3B",1
"R-HSA-5696398","R-HSA-5696398","Nucleotide Excision Repair","1/91","55/2914",0.828230050932041,0.855991952080601,0.529261975112899,"EP300",1
"R-HSA-9020702","R-HSA-9020702","Interleukin-1 signaling","1/91","57/2914",0.838992520271192,0.865503436339241,0.53514294973275,"MAP3K7",1
"R-HSA-204998","R-HSA-204998","Cell death signalling via NRAGE, NRIF and NADE","1/91","61/2914",0.858556249932632,0.884042149745103,0.546605482820111,"CASP3",1
"R-HSA-983705","R-HSA-983705","Signaling by the B Cell Receptor (BCR)","1/91","63/2914",0.867436930927849,0.8915324012314,0.551236724137385,"MAP3K7",1
"R-HSA-216083","R-HSA-216083","Integrin cell surface interactions","1/91","65/2914",0.875765774902819,0.898428844863336,0.555500812566045,"CDH1",1
"R-HSA-1474244","R-HSA-1474244","Extracellular matrix organization","3/91","157/2914",0.87798257765873,0.899041200370102,0.555879433514752,"CAPN3/CASP3/CDH1",3
"R-HSA-8856828","R-HSA-8856828","Clathrin-mediated endocytosis","1/91","66/2914",0.879733944254817,0.899175578381996,0.555962519777204,"DAB2",1
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","3/91","165/2914",0.898259914496843,0.916423258356154,0.566626803649324,"MAPK1/MAPK3/CREB1",3
"R-HSA-162906","R-HSA-162906","HIV Infection","1/91","80/2914",0.92375023646968,0.940699782092976,0.581637039283661,"TAF1",1
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","1/91","81/2914",0.926198623372029,0.941465633647392,0.582110567224372,"TP53",1
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","10/91","486/2914",0.953869900218112,0.967820465486384,0.59840582598115,"MAPK1/MAPK3/AKT2/AKT3/CREB1/RHOA/ROCK2/PAK1/FZD3/WNT1",10
"R-HSA-73894","R-HSA-73894","DNA Repair","2/91","157/2914",0.962074330724029,0.974363601371964,0.602451463342362,"TP53/EP300",2
"R-HSA-194840","R-HSA-194840","Rho GTPase cycle","1/91","106/2914",0.967487446434594,0.978061079728962,0.604737623502402,"RHOA",1
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","1/91","109/2914",0.970548112297241,0.979371276954488,0.605547721739522,"SNW1",1
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","8/91","436/2914",0.97300807567134,0.980071655168047,0.605980767349043,"MAPK1/MAPK3/AKT2/AKT3/CREB1/RHOA/ROCK2/PAK1",8
"R-HSA-382551","R-HSA-382551","Transport of small molecules","1/91","121/2914",0.980189598283435,0.98551671566541,0.609347461938215,"RAF1",1
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","2/91","217/2914",0.993322061696286,0.996914546548714,0.616394769416559,"MAPK1/CREB1",2
"R-HSA-500792","R-HSA-500792","GPCR ligand binding","2/91","317/2914",0.999705311933442,1,0.618302513039355,"FZD3/WNT1",2
"R-HSA-8866910","R-HSA-8866910","TFAP2 (AP-2) family regulates transcription of growth factors and their receptors","0/91","11/2914",1,1,0.618302513039355,"",0
